PB 1 of 2025 National Health (Listing of Pharmaceutical Benefits) Amendment (February Update) Instrument 2025 National Health Act 1953 I, REBECCA RICHARDSON, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make this Instrument under sections 84AF, 84AK, 85, 85A, 88 and 101 of the National Health Act 1953. Dated 30th January 2025 REBECCA RICHARDSON Assistant Secretary Pricing and PBS Policy Branch Technology Assessment and Access Division Contents 1. Name 2. Commencement 3. Authority 4. Schedules Schedule 1—Amendments National Health (Listing of Pharmaceutical Benefits) Instrument 2024 (PB 26 of 2024) 1. Name (1) This instrument is the National Health (Listing of Pharmaceutical Benefits) Amendment (February Update) Instrument 2025. (2) This Instrument may also be cited as PB 1 of 2025. 2. Commencement (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms. Commencement Information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this instrument 1 February 2025 1 February 2025 Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument. (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument. 3. Authority This instrument is made under sections 84AF, 84AK, 85, 85A, 88 and 101 of the National Health Act 1953. 4. Schedules Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms. Schedule 1—Amendments National Health (Listing of Pharmaceutical Benefits) Instrument 2024 (PB 26 of 2024) [1] Schedule 1, Part 1, after entry for Abemaciclib in the form Tablet 150 mg insert: Abiraterone Tablet containing abiraterone acetate 250 mg Oral Abiraterone Sandoz SZ MP C13945 120 2 120 [2] Schedule 1, Part 1, after entry for Abiraterone in the form Tablet containing abiraterone acetate 250 mg [Brand: Zytiga] insert: Abiraterone Tablet containing abiraterone acetate 500 mg Oral Abiraterone Sandoz SZ MP C13945 60 2 60 [3] Schedule 1, Part 1, entry for Aciclovir in the form Tablet 200 mg [Brand: Aciclovir APOTEX; Maximum Quantity: 90; Number of Repeats: 5] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [4] Schedule 1, Part 1, entry for Aciclovir in the form Tablet 200 mg [Brand: Aciclovir GH] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [5] Schedule 1, Part 1, entry for Aciclovir in the form Tablet 200 mg [Brand: Aciclovir Sandoz; Maximum Quantity: 90; Number of Repeats: 5] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [6] Schedule 1, Part 1, entry for Aciclovir in the form Tablet 200 mg [Brand: ACICLOVIR-WGR] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [7] Schedule 1, Part 1, entry for Aciclovir in the form Tablet 200 mg [Brand: APO-Aciclovir; Maximum Quantity: 90; Number of Repeats: 5] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [8] Schedule 1, Part 1, entry for Aciclovir in the form Tablet 200 mg [Brand: ARX-Aciclovir] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [9] Schedule 1, Part 1, entries for Adalimumab in the form Injection 40 mg in 0.4 mL pre-filled syringe omit: Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe Injection Adalicip LR MP C11713 C15473 P11713 P15473 2 0 2 Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe Injection Adalicip LR MP C12120 C14061 C14063 C14064 C14107 C14136 See Note 3 See Note 3 See Note 3 2 C(100) Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe Injection Adalicip LR MP C9715 C11709 C11715 C11716 C11759 C11761 C11852 C11854 C11855 C12098 C12101 C12147 C13602 C13609 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2 Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe Injection Adalicip LR MP C9064 C9386 C11861 C12174 C12194 C13599 C13650 C13681 C13694 C14483 C14486 C14488 C14496 C14498 C14568 C14590 C14655 C14662 C14670 C14672 C14673 P9064 P9386 P11861 P12174 P12194 P13599 P13650 P13681 P13694 P14483 P14486 P14488 P14496 P14498 P14568 P14590 P14655 P14662 P14670 P14672 P14673 2 3 2 Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe Injection Adalicip LR MP C11107 C12155 C12212 C13556 C13612 C14377 C14378 P11107 P12155 P12212 P13556 P13612 P14377 P14378 2 4 2 Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe Injection Adalicip LR MP C11523 C11524 C11579 C11604 C11606 C11631 C11635 C11704 C11711 C11717 C11718 C11767 C11853 C11865 C11867 C11903 C11906 C11966 C12122 C12123 C12148 C12156 C12157 C12158 C12189 C12190 C12214 C12228 C12240 C14493 C14499 C14507 C14567 C14656 C14683 C14701 C14713 C14730 C15445 C15446 C15450 P11523 P11524 P11579 P11604 P11606 P11631 P11635 P11704 P11711 P11717 P11718 P11767 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12189 P12190 P12214 P12228 P12240 P14493 P14499 P14507 P14567 P14656 P14683 P14701 P14713 P14730 P15445 P15446 P15450 2 5 2 Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe Injection Adalicip LR MP C15474 C15489 P15474 P15489 2 6 2 Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe Injection Adalicip LR MP C9715 C11709 C11715 C11716 C11759 C11761 C11852 C11854 C11855 C12098 C12101 C12147 C13602 C13609 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 6 0 2 [10] Schedule 1, Part 1, after entry for Amlodipine in the form Tablet 10 mg (as besilate) [Brand: APO-Amlodipine; Maximum Quantity: 60; Number of Repeats: 5] insert: Amlodipine Tablet 10 mg (as besilate) Oral APX-AMLODIPINE TW MP NP 30 5 30 Amlodipine Tablet 10 mg (as besilate) Oral APX-AMLODIPINE TW MP NP P14238 60 5 30 [11] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL [Brand: Amoxil; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [12] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL [Brand: Amoxycillin Sandoz; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [13] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL [Brand: APO‑Amoxycillin; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [14] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL [Brand: NOUMED AMOXICILLIN; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [15] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL [Brand: AMOXICILLIN-WGR; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [16] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL [Brand: Amoxil Forte; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [17] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL [Brand: Amoxycillin Sandoz; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [18] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL [Brand: APO‑Amoxycillin; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [19] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL [Brand: Cilamox; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [20] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL [Brand: NOUMED AMOXICILLIN; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [21] Schedule 1, Part 1, entry for Amoxicillin in the form Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL [Brand: Maxamox; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [22] Schedule 1, Part 1, entries for Amoxicillin in the form Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL [Brand: Amoxil; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW [23] Schedule 1, Part 1, entry for Amoxicillin with clavulanic acid in the form Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL [Brand: Curam; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [24] Schedule 1, Part 1, entry for Amoxicillin with clavulanic acid in the form Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL [Brand: Augmentin Duo 400; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [25] Schedule 1, Part 1, entry for Amoxicillin with clavulanic acid in the form Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL [Brand: Curam Duo; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [26] Schedule 1, Part 1, entries for Amoxicillin with clavulanic acid in the form Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) substitute: Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AlphaClav Duo AF MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AlphaClav Duo AF PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AlphaClav Duo AF MP NP MW C10405 P10405 20 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Alphaclav Duo Viatris AL MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Alphaclav Duo Viatris AL PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Alphaclav Duo Viatris AL MP NP MW C10405 P10405 20 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMCLAVOX DUO 500/125 RW MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMCLAVOX DUO 500/125 RW PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMCLAVOX DUO 500/125 RW MP NP MW C10405 P10405 20 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMOXICILLIN/CLAVULANIC ACID-WGR 500/125 WG MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMOXICILLIN/CLAVULANIC ACID-WGR 500/125 WG PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMOXICILLIN/CLAVULANIC ACID-WGR 500/125 WG MP NP MW C10405 P10405 20 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Amoxycillin/Clavulanic Acid 500/125 APOTEX TY MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Amoxycillin/Clavulanic Acid 500/125 APOTEX TY PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Amoxycillin/Clavulanic Acid 500/125 APOTEX TY MP NP MW C10405 P10405 20 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-AMOXY/CLAV 500/125 TW MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-AMOXY/CLAV 500/125 TW PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-AMOXY/CLAV 500/125 TW MP NP MW C10405 P10405 20 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-Amoxycillin/ Clavulanic Acid 500/125 TX MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-Amoxycillin/ Clavulanic Acid 500/125 TX PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-Amoxycillin/ Clavulanic Acid 500/125 TX MP NP MW C10405 P10405 20 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APX-Amoxicillin/Clavulanic Acid XT MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APX-Amoxicillin/Clavulanic Acid XT PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APX-Amoxicillin/Clavulanic Acid XT MP NP MW C10405 P10405 20 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Augmentin Duo AS MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Augmentin Duo AS PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Augmentin Duo AS MP NP MW C10405 P10405 20 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Curam Duo 500/125 SZ MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Curam Duo 500/125 SZ PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Curam Duo 500/125 SZ MP NP MW C10405 P10405 20 0 10 [27] Schedule 1, Part 1, entries for Amoxicillin with clavulanic acid in the form Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) substitute: Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Alphaclav Duo Forte Viatris AL PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Alphaclav Duo Forte Viatris AL MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Alphaclav Duo Forte Viatris AL MP NP MW C10413 P10413 20 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMCLAVOX DUO FORTE 875/125 RW PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMCLAVOX DUO FORTE 875/125 RW MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMCLAVOX DUO FORTE 875/125 RW MP NP MW C10413 P10413 20 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMOXICILLIN/CLAVULANIC ACID-WGR 875/125 WG PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMOXICILLIN/CLAVULANIC ACID-WGR 875/125 WG MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AMOXICILLIN/CLAVULANIC ACID-WGR 875/125 WG MP NP MW C10413 P10413 20 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AmoxyClav generichealth 875/125 HQ PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AmoxyClav generichealth 875/125 HQ MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral AmoxyClav generichealth 875/125 HQ MP NP MW C10413 P10413 20 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-AMOXY/CLAV 875/125 TW PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-AMOXY/CLAV 875/125 TW MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-AMOXY/CLAV 875/125 TW MP NP MW C10413 P10413 20 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-Amoxycillin and Clavulanic Acid TX PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-Amoxycillin and Clavulanic Acid TX MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APO-Amoxycillin and Clavulanic Acid TX MP NP MW C10413 P10413 20 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APX-Amoxicillin/Clavulanic Acid XT PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APX-Amoxicillin/Clavulanic Acid XT MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral APX-Amoxicillin/Clavulanic Acid XT MP NP MW C10413 P10413 20 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Augmentin Duo forte AS PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Augmentin Duo forte AS MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Augmentin Duo forte AS MP NP MW C10413 P10413 20 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Blooms The Chemist Amoxicillin/Clavulanic Acid 875/125 BG PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Blooms The Chemist Amoxicillin/Clavulanic Acid 875/125 BG MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Blooms The Chemist Amoxicillin/Clavulanic Acid 875/125 BG MP NP MW C10413 P10413 20 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Curam Duo Forte 875/125 SZ PDP C5833 C5894 P5833 P5894 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Curam Duo Forte 875/125 SZ MP NP MW C5832 C5893 P5832 P5893 10 0 10 Amoxicillin with clavulanic acid Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral Curam Duo Forte 875/125 SZ MP NP MW C10413 P10413 20 0 10 [28] Schedule 1, Part 1, entry for Azithromycin in the form Tablet 500 mg (as dihydrate) [Brand: APO-Azithromycin; Maximum Quantity: 2; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [29] Schedule 1, Part 1, entry for Azithromycin in the form Tablet 500 mg (as dihydrate) [Brand: Azithromycin Sandoz; Maximum Quantity: 2; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [30] Schedule 1, Part 1, entry for Azithromycin in the form Tablet 500 mg (as dihydrate) [Brand: Azithromycin Viatris; Maximum Quantity: 2; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [31] Schedule 1, Part 1, entry for Azithromycin in the form Tablet 500 mg (as dihydrate) [Brand: AZITHROMYCIN-WGR; Maximum Quantity: 2; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [32] Schedule 1, Part 1, entry for Azithromycin in the form Tablet 500 mg (as dihydrate) [Brand: ZITHRO; Maximum Quantity: 2; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [33] Schedule 1, Part 1, entry for Azithromycin in the form Tablet 500 mg (as dihydrate) [Brand: Zithromax; Maximum Quantity: 2; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [34] Schedule 1, Part 1, entry for Benzylpenicillin in the form Powder for injection 3 g (as sodium) omit from the column headed "Authorised Prescriber": MP NP PDP substitute: MP NP MW PDP [35] Schedule 1, Part 1, entry for Cabergoline in the form Tablet 500 micrograms [Brand: Dostinex; Maximum Quantity: 2; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [36] Schedule 1, Part 1, after entry for Calcipotriol with betamethasone in the form Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g [Brand: Enstilar; Maximum Quantity: 2; Number of Repeats: 1] insert: Calcipotriol with betamethasone Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g Application Klarvanta LG MP NP C6809 P6809 1 1 1 Calcipotriol with betamethasone Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g Application Klarvanta LG MP NP C14236 P14236 2 1 1 [37] Schedule 1, Part 1, entry for Cefalexin in the form Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL [Brand: Cefalexin Sandoz; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [38] Schedule 1, Part 1, entry for Cefalexin in the form Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL [Brand: Ibilex 125; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [39] Schedule 1, Part 1, entry for Cefalexin in the form Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL [Brand: Keflex; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [40] Schedule 1, Part 1, entry for Cefalexin in the form Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL [Brand: Cefalexin Sandoz; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [41] Schedule 1, Part 1, entry for Cefalexin in the form Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL [Brand: Ibilex 250; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [42] Schedule 1, Part 1, entry for Cefalexin in the form Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL [Brand: Keflex; Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [43] Schedule 1, Part 1, entries for Cefazolin substitute: Cefazolin Powder for injection 1 g (as sodium) Injection Cefazolin-AFT AE MP NP MW C15964 10 0 5 Cefazolin Powder for injection 1 g (as sodium) Injection Cefazolin-AFT AE MP NP C5883 C16029 C16030 10 0 5 Cefazolin Powder for injection 2 g (as sodium) Injection Cephazolin Viatris AL MP NP MW C15964 10 0 10 Cefazolin Powder for injection 2 g (as sodium) Injection Cephazolin Viatris AL MP NP C5867 C16029 C16030 10 0 10 [44] Schedule 1, Part 1, entries for Ceftriaxone substitute: Ceftriaxone Powder for injection 500 mg (as sodium) Injection Ceftriaxone-AFT AE MP NP MW C5855 P5855 1 0 1 Ceftriaxone Powder for injection 500 mg (as sodium) Injection Ceftriaxone-AFT AE MP NP MW C15964 P15964 5 0 1 Ceftriaxone Powder for injection 500 mg (as sodium) Injection Ceftriaxone-AFT AE MP NP C16029 C16030 P16029 P16030 5 0 1 Ceftriaxone Powder for injection 1 g (as sodium) Injection Ceftriaxone Viatris AL MP NP C16029 C16030 5 0 10 Ceftriaxone Powder for injection 1 g (as sodium) Injection Ceftriaxone Viatris AL MP NP MW C15964 5 0 10 Ceftriaxone Powder for injection 2 g (as sodium) Injection Ceftriaxone Viatris AL MP NP C16029 C16030 5 0 5 Ceftriaxone Powder for injection 2 g (as sodium) Injection Ceftriaxone Viatris AL MP NP MW C15964 5 0 5 Ceftriaxone Powder for injection 2 g (as sodium) Injection Ceftriaxone Viatris AL MP NP C16029 C16030 5 0 10 Ceftriaxone Powder for injection 2 g (as sodium) Injection Ceftriaxone Viatris AL MP NP MW C15964 5 0 10 [45] Schedule 1, Part 1, entries for Codeine omit from the column headed "Brand" (all instances): Aspen Pharma Pty Ltd substitute (all instances): Aspen Pharmacare Australia Pty Ltd [46] Schedule 1, Part 1, entry for Codeine with paracetamol in the form Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg [Brand: APO- Paracetamol/Codeine 500/30; Maximum Quantity: 10; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP PDP substitute: MP NP MW PDP [47] Schedule 1, Part 1, entry for Codeine with paracetamol in the form Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg [Brand: APX-Paracetamol/Codeine; Maximum Quantity: 10; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP PDP substitute: MP NP MW PDP [48] Schedule 1, Part 1, entry for Codeine with paracetamol in the form Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg [Brand: Codalgin Forte; Maximum Quantity: 10; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP PDP substitute: MP NP MW PDP [49] Schedule 1, Part 1, entry for Codeine with paracetamol in the form Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg [Brand: Codapane Forte 500/30; Maximum Quantity: 10; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP PDP substitute: MP NP MW PDP [50] Schedule 1, Part 1, entry for Codeine with paracetamol in the form Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg [Brand: Comfarol Forte; Maximum Quantity: 10; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP PDP substitute: MP NP MW PDP [51] Schedule 1, Part 1, entry for Codeine with paracetamol in the form Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg [Brand: Panadeine Forte; Maximum Quantity: 10; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP PDP substitute: MP NP MW PDP [52] Schedule 1, Part 1, entry for Codeine with paracetamol in the form Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg [Brand: Paracetamol/Codeine GH 500/30; Maximum Quantity: 10; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP PDP substitute: MP NP MW PDP [53] Schedule 1, Part 1, entry for Codeine with paracetamol in the form Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg [Brand: Prodeine Forte; Maximum Quantity: 10; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP PDP substitute: MP NP MW PDP [54] Schedule 1, Part 1, entries for Colestyramine omit: Colestyramine Powder for oral suspension 4 g (S19A) Oral Cholestyramine (Ascend, USA) CR MP NP 120 5 60 Colestyramine Powder for oral suspension 4 g (S19A) Oral Cholestyramine (Ascend, USA) CR MP P6429 120 11 60 [55] Schedule 1, Part 1, after entry for Dapsone in the form Tablet 25 mg insert: Dapsone Tablet 100 mg Oral DAPSOMED DZ MP NP 100 1 100 [56] Schedule 1, Part 1, entry for Dexamfetamine omit from the column headed "Brand": Aspen Pharma Pty Ltd substitute: Aspen Pharmacare Australia Pty Ltd [57] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg [Brand: Clonac 25; Maximum Quantity: 100; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [58] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg [Brand: Diclofenac Sandoz; Maximum Quantity: 100; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [59] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg [Brand: DICLOFENAC-WGR; Maximum Quantity: 100; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [60] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg [Brand: Fenac EC; Maximum Quantity: 100; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [61] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg [Brand: Voltaren 25; Maximum Quantity: 100; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [62] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg [Brand: Clonac 50; Maximum Quantity: 50; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [63] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg [Brand: Diclofenac Sandoz; Maximum Quantity: 50; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [64] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg [Brand: DICLOFENAC-WGR; Maximum Quantity: 50; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [65] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg [Brand: Fenac EC; Maximum Quantity: 50; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [66] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg [Brand: Voltaren 50; Maximum Quantity: 50; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [67] Schedule 1, Part 1, entry for Doxycycline in the form Capsule 100 mg (as hyclate) (containing enteric coated pellets) [Brand: Doryx; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [68] Schedule 1, Part 1, entry for Doxycycline in the form Capsule 100 mg (as hyclate) (containing enteric coated pellets) [Brand: Mayne Pharma Doxycycline; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [69] Schedule 1, Part 1, entry for Doxycycline in the form Tablet 100 mg (as hyclate) [Brand: APX-Doxycycline; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [70] Schedule 1, Part 1, entry for Doxycycline in the form Tablet 100 mg (as hyclate) [Brand: Doxsig; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [71] Schedule 1, Part 1, entry for Doxycycline in the form Tablet 100 mg (as hyclate) [Brand: DOXYCYCLINE-WGR; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [72] Schedule 1, Part 1, entry for Doxycycline in the form Tablet 100 mg (as hyclate) [Brand: Doxylin 100; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [73] Schedule 1, Part 1, entry for Doxycycline in the form Tablet 100 mg (as monohydrate) [Brand: Doxycycline Sandoz; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [74] Schedule 1, Part 1, entries for Enoxaparin substitute: Enoxaparin Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe Injection Clexane Safety-Lock AV MP NP MW C16261 P16261 20 1 10 Enoxaparin Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe Injection Clexane Safety-Lock AV MP NP C4910 P4910 20 3 10 Enoxaparin Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe Injection Exarane JU MP NP MW C16261 P16261 20 1 10 Enoxaparin Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe Injection Exarane JU MP NP C4910 P4910 20 3 10 Enoxaparin Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe Injection Clexane Safety-Lock AV MP NP MW C16261 P16261 20 1 10 Enoxaparin Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe Injection Clexane Safety-Lock AV MP NP C4910 P4910 20 3 10 Enoxaparin Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe Injection Exarane JU MP NP MW C16261 P16261 20 1 10 Enoxaparin Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe Injection Exarane JU MP NP C4910 P4910 20 3 10 Enoxaparin Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe Injection Clexane Safety-Lock AV MP NP MW C16261 P16261 10 1 10 Enoxaparin Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe Injection Clexane Safety-Lock AV MP NP C4910 P4910 20 3 10 Enoxaparin Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe Injection Exarane JU MP NP MW C16261 P16261 10 1 10 Enoxaparin Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe Injection Exarane JU MP NP C4910 P4910 20 3 10 Enoxaparin Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe Injection Clexane Safety-Lock AV MP NP MW C16261 P16261 10 1 10 Enoxaparin Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe Injection Clexane Safety-Lock AV MP NP C4910 P4910 20 3 10 Enoxaparin Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe Injection Exarane JU MP NP MW C16261 P16261 10 1 10 Enoxaparin Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe Injection Exarane JU MP NP C4910 P4910 20 3 10 Enoxaparin Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe Injection Clexane Safety-Lock AV MP NP MW C16261 P16261 10 1 10 Enoxaparin Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe Injection Clexane Safety-Lock AV MP NP C4910 P4910 20 3 10 Enoxaparin Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe Injection Exarane JU MP NP MW C16261 P16261 10 1 10 Enoxaparin Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe Injection Exarane JU MP NP C4910 P4910 20 3 10 Enoxaparin Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe Injection Clexane Forte Safety-Lock AV MP NP MW C16261 10 1 10 Enoxaparin Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe Injection Exarane Forte JU MP NP MW C16261 P16261 10 1 10 Enoxaparin Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe Injection Exarane Forte JU MP NP C4910 P4910 10 3 10 Enoxaparin Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe Injection Clexane Forte Safety-Lock AV MP NP MW C16261 10 1 10 Enoxaparin Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe Injection Exarane Forte JU MP NP MW C16261 P16261 10 1 10 Enoxaparin Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe Injection Exarane Forte JU MP NP C4910 P4910 10 3 10 [75] Schedule 1, Part 1, entry for Erythromycin in the form Capsule 250 mg (containing enteric coated pellets) [Maximum Quantity: 25; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [76] Schedule 1, Part 1, entry for Erythromycin in the form Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL [Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [77] Schedule 1, Part 1, entry for Erythromycin in the form Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL [Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [78] Schedule 1, Part 1, entry for Esomeprazole in the form Capsule (enteric) 20 mg (as magnesium) [Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Capsule (enteric) 20 mg (as magnesium) Oral Noxicid Caps AL MP NP MW C8774 P8774 30 1 30 Esomeprazole Capsule (enteric) 20 mg (as magnesium) Oral Noxicid Caps AL MP NP C8775 P8775 30 1 30 [79] Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium) [Brand: APO-Esomeprazole; Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral APO-Esomeprazole TY MP NP MW C8774 P8774 30 1 30 Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral APO-Esomeprazole TY MP NP C8775 P8775 30 1 30 [80] Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium) [Brand: Esomeprazole GH; Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Esomeprazole GH GQ MP NP MW C8774 P8774 30 1 30 Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Esomeprazole GH GQ MP NP C8775 P8775 30 1 30 [81] Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium) [Brand: Esomeprazole GxP; Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Esomeprazole GxP AF MP NP MW C8774 P8774 30 1 30 Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Esomeprazole GxP AF MP NP C8775 P8775 30 1 30 [82] Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium) [Brand: Esomeprazole RBX; Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Esomeprazole RBX RA MP NP MW C8774 P8774 30 1 30 Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Esomeprazole RBX RA MP NP C8775 P8775 30 1 30 [83] Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium) [Brand: Esomeprazole Viatris; Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Esomeprazole Viatris MQ MP NP MW C8774 P8774 30 1 30 Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Esomeprazole Viatris MQ MP NP C8775 P8775 30 1 30 [84] Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium) [Brand: ESOMEPRAZOLE-WGR; Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral ESOMEPRAZOLE-WGR WG MP NP MW C8774 P8774 30 1 30 Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral ESOMEPRAZOLE-WGR WG MP NP C8775 P8775 30 1 30 [85] Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium) [Brand: Esopreze; Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Esopreze BG MP NP MW C8774 P8774 30 1 30 Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Esopreze BG MP NP C8775 P8775 30 1 30 [86] Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium) [Brand: Nexazole; Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Nexazole RW MP NP MW C8774 P8774 30 1 30 Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Nexazole RW MP NP C8775 P8775 30 1 30 [87] Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium) [Brand: Nexium; Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Nexium AP MP NP MW C8774 P8774 30 1 30 Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Nexium AP MP NP C8775 P8775 30 1 30 [88] Schedule 1, Part 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium) [Brand: Nexole; Maximum Quantity: 30; Number of Repeats: 1] substitute: Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Nexole RF MP NP MW C8774 P8774 30 1 30 Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) Oral Nexole RF MP NP C8775 P8775 30 1 30 [89] Schedule 1, Part 1, after entry for Estradiol in the form Transdermal patches 390 micrograms, 8 insert: Estradiol Transdermal patches 390 micrograms, 24 (S19A) Transdermal Estramon (Germany, Sandoz) SZ MP NP 1 1 1 [90] Schedule 1, Part 1, after entry for Estradiol in the form Transdermal patches 780 micrograms, 8 insert: Estradiol Transdermal patches 780 micrograms, 24 (S19A) Transdermal Estramon (Germany, Sandoz) SZ MP NP 1 1 1 [91] Schedule 1, Part 1, after entry for Estradiol in the form Transdermal patches 1.17 mg, 8 [Brand: Estradot 75] insert: Estradiol Transdermal patches 1.17 mg, 24 (S19A) Transdermal Estramon (Germany, Sandoz) SZ MP NP 1 1 1 [92] Schedule 1, Part 1, after entry for Fenofibrate in the form Tablet 48 mg [Brand: Fenofibrate Cipla; Maximum Quantity: 120; Number of Repeats: 5] insert: Fenofibrate Tablet 48 mg Oral Fenofibrate Lupin GQ MP NP 60 5 60 Fenofibrate Tablet 48 mg Oral Fenofibrate Lupin GQ MP NP P14238 120 5 60 [93] Schedule 1, Part 1, after entry for Fenofibrate in the form Tablet 145 mg [Brand: Fenofibrate Cipla; Maximum Quantity: 60; Number of Repeats: 5] insert: Fenofibrate Tablet 145 mg Oral Fenofibrate Lupin GQ MP NP 30 5 30 Fenofibrate Tablet 145 mg Oral Fenofibrate Lupin GQ MP NP P14238 60 5 30 [94] Schedule 1, Part 1, entries for Ferric carboxymaltose omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW [95] Schedule 1, Part 1, entry for Ferrous fumarate omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [96] Schedule 1, Part 1, entry for Ferrous fumarate with folic acid omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [97] Schedule 1, Part 1, entry for Flucloxacillin in the form Powder for injection 1 g (as sodium monohydrate) [Maximum Quantity: 5; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [98] Schedule 1, Part 1, entry for Flucloxacillin in the form Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL [Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [99] Schedule 1, Part 1, entry for Flucloxacillin in the form Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL [Maximum Quantity: 1; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [100] Schedule 1, Part 1, entries for Folic acid substitute: Folic acid Tablet 500 micrograms Oral Foltabs 500 PP MP NP MW C5824 200 0 100 Folic acid Tablet 500 micrograms Oral Megafol 0.5 AF MP NP MW C5824 200 0 100 Folic acid Tablet 5 mg Oral Megafol 5 AF MP NP MW C5824 200 1 100 [101] Schedule 1, Part 1, entries for Ganirelix substitute: Ganirelix Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe Injection ARX Ganirelix XT MP C5046 10 0 1 D(100) Ganirelix Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe Injection ARX Ganirelix XT MP C5046 10 0 5 D(100) Ganirelix Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe Injection GANIRELIX SUN RA MP C5046 10 0 1 D(100) Ganirelix Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe Injection GANIRELIX SUN RA MP C5046 10 0 5 D(100) Ganirelix Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe Injection Ganirelix Theramex TT MP C5046 10 0 5 D(100) Ganirelix Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe Injection Orgalutran OQ MP C5046 10 0 1 D(100) Ganirelix Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe Injection Orgalutran OQ MP C5046 10 0 5 D(100) [102] Schedule 1, Part 1, entry for Gentamicin omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [103] Schedule 1, Part 1, entries for Hydroxocobalamin substitute: Hydroxocobalamin Injection 1 mg (as acetate) in 1 mL Injection Cobal-B12 JU MP NP MW C16269 C16288 C16289 3 0 3 Hydroxocobalamin Injection 1 mg (as acetate) in 1 mL Injection Vita-B12 GH MP NP MW C16269 C16288 C16289 3 0 3 Hydroxocobalamin Injection 1 mg (as chloride) in 1 mL Injection Hydroxo-B12 AS MP NP MW C16269 C16288 C16289 3 0 3 Hydroxocobalamin Injection 1 mg (as chloride) in 1 mL Injection Neo-B12 PF MP NP MW C16269 C16288 C16289 3 0 3 [104] Schedule 1, Part 1, entry for Indometacin in the form Suppository 100 mg [Maximum Quantity: 40; Number of Repeats: 3] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [105] Schedule 1, Part 1, entry for Iron polymaltose complex [Maximum Quantity: 5; Number of Repeats: 0] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [106] Schedule 1, Part 1, entry for Labetalol [Maximum Quantity: 100; Number of Repeats: 5] (a) omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW (b) insert in the column headed "Circumstances": C16261 (c) insert in the column headed "Purposes": P16261 [107] Schedule 1, Part 1, entry for Labetalol [Maximum Quantity: 200; Number of Repeats: 5] insert in the column headed "Circumstances": C14238 [108] Schedule 1, Part 1, entry for Levonorgestrel in the form Intrauterine drug delivery system 19.5 mg omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [109] Schedule 1, Part 1, entry for Levonorgestrel in the form Intrauterine drug delivery system 52 mg substitute: Levonorgestrel Intrauterine drug delivery system 52 mg Intrauterine Mirena BN MP NP MW C5214 1 0 1 Levonorgestrel Intrauterine drug delivery system 52 mg Intrauterine Mirena BN MP NP C5135 C5289 1 0 1 [110] Schedule 1, Part 1, entry for Levothyroxine in the form Tablet containing 50 micrograms anhydrous levothyroxine sodium (a) omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW (b) insert in the column headed "Circumstances" (all instances): C16261 [111] Schedule 1, Part 1, entries for Levothyroxine in the form Tablet containing 75 micrograms anhydrous levothyroxine sodium (a) omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW (b) insert in the column headed "Circumstances" (all instances): C16261 [112] Schedule 1, Part 1, entries for Levothyroxine in the form Tablet containing 100 micrograms anhydrous levothyroxine sodium (a) omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW (b) insert in the column headed "Circumstances" (all instances): C16261 [113] Schedule 1, Part 1, entry for Levothyroxine in the form Tablet containing 125 micrograms anhydrous levothyroxine sodium (a) omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW (b) insert in the column headed "Circumstances": C16261 [114] Schedule 1, Part 1, entries for Levothyroxine in the form Tablet containing 200 micrograms anhydrous levothyroxine sodium (a) omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW (b) insert in the column headed "Circumstances" (all instances): C16261 [115] Schedule 1, Part 1, entry for Lidocaine in the form Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL omit from the column headed "Section 100/ Prescriber Bag only": PB(MP) PB(NP) substitute: PB(MP) PB(NP) PB(MW) [116] Schedule 1, Part 1, after entry for Maraviroc in the form Tablet 150 mg insert: Maraviroc Tablet 150 mg Oral Maraviroc Waymade IX MP NP C5008 120 5 60 D(100) [117] Schedule 1, Part 1, after entry for Maraviroc in the form Tablet 300 mg insert: Maraviroc Tablet 300 mg Oral Maraviroc Waymade IX MP NP C5008 120 5 60 D(100) [118] Schedule 1, Part 1, entry for Medroxyprogesterone in the form Injection containing medroxyprogesterone acetate 150 mg in 1 mL pre-filled syringe omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [119] Schedule 1, Part 1, entries for Metformin substitute: Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral APO-Metformin XR 500 TX MP NP MW C16261 P16261 120 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral APO-Metformin XR 500 TX MP NP C14238 P14238 240 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral Diabex XR 500 AL MP NP MW C16261 P16261 120 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral Diabex XR 500 AL MP NP C14238 P14238 240 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral Diaformin Alphapharm XR MQ MP NP MW C16261 P16261 120 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral Diaformin Alphapharm XR MQ MP NP C14238 P14238 240 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral Metex XR RW MP NP MW C16261 P16261 120 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral Metex XR RW MP NP C14238 P14238 240 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral METFORMIN-WGR XR WG MP NP MW C16261 P16261 120 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral METFORMIN-WGR XR WG MP NP C14238 P14238 240 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral Pharmacor Metformin XR CR MP NP MW C16261 P16261 120 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral Pharmacor Metformin XR CR MP NP C14238 P14238 240 5 120 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral APO-Metformin XR 1000 TX MP NP MW C16261 P16261 60 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral APO-Metformin XR 1000 TX MP NP C14238 P14238 120 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral Diabex XR 1000 AL MP NP MW C16261 P16261 60 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral Diabex XR 1000 AL MP NP C14238 P14238 120 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral Diaformin Alphapharm XR MQ MP NP MW C16261 P16261 60 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral Diaformin Alphapharm XR MQ MP NP C14238 P14238 120 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral Diaformin XR 1000 AF MP NP MW C16261 P16261 60 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral Diaformin XR 1000 AF MP NP C14238 P14238 120 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral METEX XR RF MP NP MW C16261 P16261 60 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral METEX XR RF MP NP C14238 P14238 120 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral METFORMIN-WGR XR WG MP NP MW C16261 P16261 60 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral METFORMIN-WGR XR WG MP NP C14238 P14238 120 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral Pharmacor Metformin XR CR MP NP MW C16261 P16261 60 5 60 Metformin Tablet (extended release) containing metformin hydrochloride 1 g Oral Pharmacor Metformin XR CR MP NP C14238 P14238 120 5 60 Metformin Tablet containing metformin hydrochloride 500 mg Oral APX-METFORMIN TY MP NP MW C16261 P16261 100 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral APX-METFORMIN TY MP NP C14238 P14238 200 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Blooms The Chemist Metformin 500 mg BG MP NP MW C16261 P16261 100 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Blooms The Chemist Metformin 500 mg BG MP NP C14238 P14238 200 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Diabex AL MP NP MW C16261 P16261 100 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Diabex AL MP NP C14238 P14238 200 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Diaformin AF MP NP MW C16261 P16261 100 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Diaformin AF MP NP C14238 P14238 200 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Diaformin Viatris MQ MP NP MW C16261 P16261 100 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Diaformin Viatris MQ MP NP C14238 P14238 200 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral FORMET 500 RF MP NP MW C16261 P16261 100 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral FORMET 500 RF MP NP C14238 P14238 200 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Glucobete 500 ZS MP NP MW C16261 P16261 100 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Glucobete 500 ZS MP NP C14238 P14238 200 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Metformin GH HQ MP NP MW C16261 P16261 100 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Metformin GH HQ MP NP C14238 P14238 200 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Metformin Sandoz SZ MP NP MW C16261 P16261 100 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral Metformin Sandoz SZ MP NP C14238 P14238 200 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral METFORMIN-WGR WG MP NP MW C16261 P16261 100 5 100 Metformin Tablet containing metformin hydrochloride 500 mg Oral METFORMIN-WGR WG MP NP C14238 P14238 200 5 100 Metformin Tablet containing metformin hydrochloride 850 mg Oral APX-METFORMIN TY MP NP MW C16261 P16261 60 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral APX-METFORMIN TY MP NP C14238 P14238 120 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Blooms The Chemist Metformin 850 mg BG MP NP MW C16261 P16261 60 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Blooms The Chemist Metformin 850 mg BG MP NP C14238 P14238 120 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Diabex 850 AL MP NP MW C16261 P16261 60 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Diabex 850 AL MP NP C14238 P14238 120 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Diaformin 850 AF MP NP MW C16261 P16261 60 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Diaformin 850 AF MP NP C14238 P14238 120 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Diaformin Viatris MQ MP NP MW C16261 P16261 60 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Diaformin Viatris MQ MP NP C14238 P14238 120 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral FORMET 850 RF MP NP MW C16261 P16261 60 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral FORMET 850 RF MP NP C14238 P14238 120 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Glucobete 850 ZS MP NP MW C16261 P16261 60 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Glucobete 850 ZS MP NP C14238 P14238 120 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Metformin Sandoz SZ MP NP MW C16261 P16261 60 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral Metformin Sandoz SZ MP NP C14238 P14238 120 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral METFORMIN-WGR WG MP NP MW C16261 P16261 60 5 60 Metformin Tablet containing metformin hydrochloride 850 mg Oral METFORMIN-WGR WG MP NP C14238 P14238 120 5 60 Metformin Tablet containing metformin hydrochloride 1 g Oral APX-METFORMIN TY MP NP MW C16261 P16261 90 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral APX-METFORMIN TY MP NP C14238 P14238 180 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Blooms The Chemist Metformin 1000 mg BG MP NP MW C16261 P16261 90 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Blooms The Chemist Metformin 1000 mg BG MP NP C14238 P14238 180 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Diabex 1000 AL MP NP MW C16261 P16261 90 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Diabex 1000 AL MP NP C14238 P14238 180 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Diaformin 1000 AF MP NP MW C16261 P16261 90 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Diaformin 1000 AF MP NP C14238 P14238 180 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Diaformin Viatris MQ MP NP MW C16261 P16261 90 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Diaformin Viatris MQ MP NP C14238 P14238 180 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Formet 1000 RW MP NP MW C16261 P16261 90 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Formet 1000 RW MP NP C14238 P14238 180 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Glucobete 1000 ZS MP NP MW C16261 P16261 90 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Glucobete 1000 ZS MP NP C14238 P14238 180 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Metformin GH HQ MP NP MW C16261 P16261 90 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Metformin GH HQ MP NP C14238 P14238 180 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Metformin Sandoz SZ MP NP MW C16261 P16261 90 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral Metformin Sandoz SZ MP NP C14238 P14238 180 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral METFORMIN-WGR WG MP NP MW C16261 P16261 90 5 90 Metformin Tablet containing metformin hydrochloride 1 g Oral METFORMIN-WGR WG MP NP C14238 P14238 180 5 90 [120] Schedule 1, Part 1, after entry for Methotrexate in the form Tablet 10 mg [Brand: ARX-Methotrexate; Maximum Quantity: 50; Number of Repeats: 2] insert: Methotrexate Tablet 10 mg Oral Chexate OX MP NP 10 5 10 [121] Schedule 1, Part 1, entries for Methyldopa (a) omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW (b) omit from the column headed "Circumstances" (all instances): C13887 substitute (all instances): C16273 [122] Schedule 1, Part 1, entries for Methylphenidate in the form Tablet containing methylphenidate hydrochloride 18 mg (extended release) omit from the column headed "Circumstances" (all instances): C16189 substitute (all instances): C16274 [123] Schedule 1, Part 1, entries for Methylphenidate in the form Tablet containing methylphenidate hydrochloride 27 mg (extended release) omit from the column headed "Circumstances" (all instances): C16189 substitute (all instances): C16274 [124] Schedule 1, Part 1, entries for Methylphenidate in the form Tablet containing methylphenidate hydrochloride 36 mg (extended release) omit from the column headed "Circumstances" (all instances): C16189 substitute (all instances): C16274 [125] Schedule 1, Part 1, entries for Methylphenidate in the form Tablet containing methylphenidate hydrochloride 54 mg (extended release) omit from the column headed "Circumstances" (all instances): C16189 substitute (all instances): C16274 [126] Schedule 1, Part 1, entry for Metronidazole in the form Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL omit from the column headed "Authorised Prescriber": MP NP PDP substitute: MP NP MW PDP [127] Schedule 1, Part 1, entry for Metronidazole in the form Tablet 200 mg [Brand: Metrogyl 200; Maximum Quantity: 21; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [128] Schedule 1, Part 1, entry for Metronidazole in the form Tablet 200 mg [Brand: METRONIDAMED; Maximum Quantity: 21; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [129] Schedule 1, Part 1, entry for Metronidazole in the form Tablet 400 mg [Brand: Flagyl; Maximum Quantity: 21; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [130] Schedule 1, Part 1, entry for Metronidazole in the form Tablet 400 mg [Brand: Metrogyl 400; Maximum Quantity: 21; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [131] Schedule 1, Part 1, entry for Metronidazole in the form Tablet 400 mg [Brand: METRONIDAMED; Maximum Quantity: 21; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [132] Schedule 1, Part 1, entries for Mirtazapine in the form Tablet 45 mg omit: Mirtazapine Tablet 45 mg Oral NOUMED MIRTAZAPINE VO MP NP C5650 P5650 30 5 30 Mirtazapine Tablet 45 mg Oral NOUMED MIRTAZAPINE VO MP NP C15553 P15553 60 2 30 [133] Schedule 1, Part 1, entries for Naloxone substitute: Naloxone Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule Injection Naloxone Hydrochloride (DBL) PF MP NP MW PDP 5 0 5 Naloxone Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule Injection Naloxone Juno JU MP NP MW PDP 5 0 5 Naloxone Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule Injection NALOXONE SXP XN MP NP MW PDP 5 0 5 Naloxone Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule Injection NARCAN FF See Note 4 See Note 4 See Note 4 See Note 4 See Note 4 10 10 PB(MP) PB(NP) PB(MW) Naloxone Injection containing naloxone hydrochloride 2 mg in 2 mL pre-filled syringe Injection Prenoxad FF MP NP MW PDP 1 0 1 Naloxone Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2 Nasal Nyxoid MF MP NP MW PDP 1 0 1 [134] Schedule 1, Part 1, entry for Norethisterone in the form Tablets 350 micrograms, 28 omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [135] Schedule 1, Part 1, entries for Omeprazole substitute: Omeprazole Capsule 20 mg Oral APO-Omeprazole TX MP NP MW C8774 P8774 30 1 30 Omeprazole Capsule 20 mg Oral APO-Omeprazole TX MP NP C8775 P8775 30 1 30 Omeprazole Capsule 20 mg Oral APO-Omeprazole TX MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Capsule 20 mg Oral APO-Omeprazole TX MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Capsule 20 mg Oral APO-Omeprazole TX MP C11310 P11310 60 5 30 Omeprazole Capsule 20 mg Oral APO-Omeprazole TX MP C15856 P15856 120 5 30 Omeprazole Capsule 20 mg Oral Maxor AF MP NP MW C8774 P8774 30 1 30 Omeprazole Capsule 20 mg Oral Maxor AF MP NP C8775 P8775 30 1 30 Omeprazole Capsule 20 mg Oral Maxor AF MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Capsule 20 mg Oral Maxor AF MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Capsule 20 mg Oral Maxor AF MP C11310 P11310 60 5 30 Omeprazole Capsule 20 mg Oral Maxor AF MP C15856 P15856 120 5 30 Omeprazole Capsule 20 mg Oral OMEPRAZOLE CAPS WGR WG MP NP MW C8774 P8774 30 1 30 Omeprazole Capsule 20 mg Oral OMEPRAZOLE CAPS WGR WG MP NP C8775 P8775 30 1 30 Omeprazole Capsule 20 mg Oral OMEPRAZOLE CAPS WGR WG MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Capsule 20 mg Oral OMEPRAZOLE CAPS WGR WG MP C11310 P11310 60 5 30 Omeprazole Capsule 20 mg Oral OMEPRAZOLE CAPS WGR WG MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Capsule 20 mg Oral OMEPRAZOLE CAPS WGR WG MP C15856 P15856 120 5 30 Omeprazole Capsule 20 mg Oral Omeprazole Sandoz HX MP NP MW C8774 P8774 30 1 30 Omeprazole Capsule 20 mg Oral Omeprazole Sandoz HX MP NP C8775 P8775 30 1 30 Omeprazole Capsule 20 mg Oral Omeprazole Sandoz HX MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Capsule 20 mg Oral Omeprazole Sandoz HX MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Capsule 20 mg Oral Omeprazole Sandoz HX MP C11310 P11310 60 5 30 Omeprazole Capsule 20 mg Oral Omeprazole Sandoz HX MP C15856 P15856 120 5 30 Omeprazole Capsule 20 mg Oral Pemzo RW MP NP MW C8774 P8774 30 1 30 Omeprazole Capsule 20 mg Oral Pemzo RW MP NP C8775 P8775 30 1 30 Omeprazole Capsule 20 mg Oral Pemzo RW MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Capsule 20 mg Oral Pemzo RW MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Capsule 20 mg Oral Pemzo RW MP C11310 P11310 60 5 30 Omeprazole Capsule 20 mg Oral Pemzo RW MP C15856 P15856 120 5 30 Omeprazole Capsule 20 mg Oral Pharmacor Omeprazole 20 CR MP NP MW C8774 P8774 30 1 30 Omeprazole Capsule 20 mg Oral Pharmacor Omeprazole 20 CR MP NP C8775 P8775 30 1 30 Omeprazole Capsule 20 mg Oral Pharmacor Omeprazole 20 CR MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Capsule 20 mg Oral Pharmacor Omeprazole 20 CR MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Capsule 20 mg Oral Pharmacor Omeprazole 20 CR MP C11310 P11310 60 5 30 Omeprazole Capsule 20 mg Oral Pharmacor Omeprazole 20 CR MP C15856 P15856 120 5 30 Omeprazole Capsule 20 mg Oral Probitor SZ MP NP MW C8774 P8774 30 1 30 Omeprazole Capsule 20 mg Oral Probitor SZ MP NP C8775 P8775 30 1 30 Omeprazole Capsule 20 mg Oral Probitor SZ MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Capsule 20 mg Oral Probitor SZ MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Capsule 20 mg Oral Probitor SZ MP C11310 P11310 60 5 30 Omeprazole Capsule 20 mg Oral Probitor SZ MP C15856 P15856 120 5 30 Omeprazole Tablet 10 mg (as magnesium) Oral Losec Tablets PB MP NP MW C5444 P5444 30 5 30 Omeprazole Tablet 10 mg (as magnesium) Oral Losec Tablets PB MP NP C5512 C5529 P5512 P5529 30 5 30 Omeprazole Tablet 10 mg (as magnesium) Oral Losec Tablets PB MP NP C15574 C15575 C15633 P15574 P15575 P15633 60 5 30 Omeprazole Tablet 20 mg Oral APO-Omeprazole TX MP NP MW C8774 P8774 30 1 30 Omeprazole Tablet 20 mg Oral APO-Omeprazole TX MP NP C8775 P8775 30 1 30 Omeprazole Tablet 20 mg Oral APO-Omeprazole TX MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Tablet 20 mg Oral APO-Omeprazole TX MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Tablet 20 mg Oral APO-Omeprazole TX MP C11310 P11310 60 5 30 Omeprazole Tablet 20 mg Oral APO-Omeprazole TX MP C15856 P15856 120 5 30 Omeprazole Tablet 20 mg Oral Maxor EC Tabs AF MP NP MW C8774 P8774 30 1 30 Omeprazole Tablet 20 mg Oral Maxor EC Tabs AF MP NP C8775 P8775 30 1 30 Omeprazole Tablet 20 mg Oral Maxor EC Tabs AF MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Tablet 20 mg Oral Maxor EC Tabs AF MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Tablet 20 mg Oral Maxor EC Tabs AF MP C11310 P11310 60 5 30 Omeprazole Tablet 20 mg Oral Maxor EC Tabs AF MP C15856 P15856 120 5 30 Omeprazole Tablet 20 mg Oral Ozmep RW MP NP MW C8774 P8774 30 1 30 Omeprazole Tablet 20 mg Oral Ozmep RW MP NP C8775 P8775 30 1 30 Omeprazole Tablet 20 mg Oral Ozmep RW MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Tablet 20 mg Oral Ozmep RW MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Tablet 20 mg Oral Ozmep RW MP C11310 P11310 60 5 30 Omeprazole Tablet 20 mg Oral Ozmep RW MP C15856 P15856 120 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Acimax Tablets FJ MP NP MW C8774 P8774 30 1 30 Omeprazole Tablet 20 mg (as magnesium) Oral Acimax Tablets FJ MP NP C8775 P8775 30 1 30 Omeprazole Tablet 20 mg (as magnesium) Oral Acimax Tablets FJ MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Acimax Tablets FJ MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Acimax Tablets FJ MP C11310 P11310 60 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Acimax Tablets FJ MP C15856 P15856 120 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Losec Tablets PB MP NP MW C8774 P8774 30 1 30 Omeprazole Tablet 20 mg (as magnesium) Oral Losec Tablets PB MP NP C8775 P8775 30 1 30 Omeprazole Tablet 20 mg (as magnesium) Oral Losec Tablets PB MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Losec Tablets PB MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Losec Tablets PB MP C11310 P11310 60 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Losec Tablets PB MP C15856 P15856 120 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omepral FQ MP NP MW C8774 P8774 30 1 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omepral FQ MP NP C8775 P8775 30 1 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omepral FQ MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omepral FQ MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omepral FQ MP C11310 P11310 60 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omepral FQ MP C15856 P15856 120 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omeprazole Sandoz SZ MP NP MW C8774 P8774 30 1 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omeprazole Sandoz SZ MP NP C8775 P8775 30 1 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omeprazole Sandoz SZ MP NP C8776 C8780 C8866 P8776 P8780 P8866 30 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omeprazole Sandoz SZ MP NP C15530 C15658 C15678 P15530 P15658 P15678 60 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omeprazole Sandoz SZ MP C11310 P11310 60 5 30 Omeprazole Tablet 20 mg (as magnesium) Oral Omeprazole Sandoz SZ MP C15856 P15856 120 5 30 [136] Schedule 1, Part 1, entries for Oxycodone in the form Capsule containing oxycodone hydrochloride 5 mg substitute: Oxycodone Capsule containing oxycodone hydrochloride 5 mg Oral Oxycodone BNM BZ PDP C10768 P10768 20 0 20 Oxycodone Capsule containing oxycodone hydrochloride 5 mg Oral Oxycodone BNM BZ MP NP C10764 C10771 C10772 P10764 P10771 P10772 20 0 V10764 V10771 V10772 20 Oxycodone Capsule containing oxycodone hydrochloride 5 mg Oral OxyNorm MF MP NP MW C16276 P16276 10 0 10 Oxycodone Capsule containing oxycodone hydrochloride 5 mg Oral OxyNorm MF PDP C10766 P10766 10 0 10 Oxycodone Capsule containing oxycodone hydrochloride 5 mg Oral OxyNorm MF PDP C10768 P10768 20 0 20 Oxycodone Capsule containing oxycodone hydrochloride 5 mg Oral OxyNorm MF MP NP C10764 C10771 C10772 P10764 P10771 P10772 20 0 V10764 V10771 V10772 20 [137] Schedule 1, Part 1, entries for Oxycodone in the form Tablet containing oxycodone hydrochloride 5 mg substitute: Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral ENDONE AF MP NP MW C16276 P16276 10 0 10 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral ENDONE AF PDP C10766 P10766 10 0 10 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral ENDONE AF MP NP C10764 C10771 C10772 P10764 P10771 P10772 20 0 V10764 V10771 V10772 20 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral ENDONE AF PDP C10768 P10768 20 0 20 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral Mayne Pharma Oxycodone IR SZ MP NP C10764 C10771 C10772 20 0 V10764 V10771 V10772 20 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral Mayne Pharma Oxycodone IR SZ PDP C10768 20 0 20 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral Oxycodone Viatris MQ MP NP MW C16276 P16276 10 0 10 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral Oxycodone Viatris MQ PDP C10766 P10766 10 0 10 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral Oxycodone Viatris MQ MP NP C10764 C10771 C10772 P10764 P10771 P10772 20 0 V10764 V10771 V10772 20 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral Oxycodone Viatris MQ PDP C10768 P10768 20 0 20 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral Oxyndone TX MP NP C10764 C10771 C10772 20 0 V10764 V10771 V10772 20 Oxycodone Tablet containing oxycodone hydrochloride 5 mg Oral Oxyndone TX PDP C10768 20 0 20 [138] Schedule 1, Part 1, entries for Paclitaxel, nanoparticle albumin-bound substitute: Paclitaxel, nanoparticle albumin-bound Powder for I.V. injection containing 100 mg paclitaxel Injection Abraxane TS MP C4657 C6106 C6119 See Note 3 See Note 3 1 D(100 Paclitaxel, nanoparticle albumin-bound Powder for I.V. injection containing 100 mg paclitaxel Injection nab-PACLITAXEL JUNO JU MP C4657 C6106 C6119 See Note 3 See Note 3 1 D(100) [139] Schedule 1, Part 1, entries for Pembrolizumab substitute: Pembrolizumab Solution concentrate for I.V. infusion 100 mg in 4 mL Injection Keytruda MK MP C10676 C10688 C10701 C10705 C13432 C13437 C13726 C13727 C13728 C13730 C13731 C13732 C13735 C13736 C13739 C13741 C13948 C13949 C14027 C14044 C14324 C14403 C14404 C14727 C14770 C14786 C14817 C14818 C16264 C16280 See Note 3 See Note 3 1 D(100) [140] Schedule 1, Part 1, after entry for Pirfenidone in the form Tablet 801mg [Brand: Pirfenidone Sandoz] insert: Pirfenidone Tablet 267 mg Oral ARX-Pirfenidone XW MP C13378 C13380 C13381 270 5 90 [141] Schedule 1, Part 1, entries for Prochlorperazine omit from the column headed "Authorised Prescriber" (all instances): MP NP PDP substitute (all instances): MP NP MW PDP [142] Schedule 1, Part 1, entries for Promethazine substitute: Promethazine Injection containing promethazine hydrochloride 50 mg in 2 mL Injection DBL Promethazine Hydrochloride PF MP NP MW PDP 10 0 5 [143] Schedule 1, Part 1, after entry for Rivaroxaban in the form Tablet 2.5 mg [Brand: Xarelto; Maximum Quantity: 120; Number of Repeats: 5] insert: Rivaroxaban Tablet 10 mg Oral ARX-Rivaroxaban 10 XT MP NP C4382 P4382 15 0 15 Rivaroxaban Tablet 10 mg Oral ARX-Rivaroxaban 10 XT MP NP C4402 P4402 15 1 15 Rivaroxaban Tablet 10 mg Oral ARX-Rivaroxaban 10 XT MP NP C4402 P4402 30 0 30 Rivaroxaban Tablet 10 mg Oral ARX-Rivaroxaban 10 XT MP NP C4132 P4132 30 5 30 Rivaroxaban Tablet 10 mg Oral ARX-Rivaroxaban 10 XT MP NP C14300 P14300 60 5 30 [144] Schedule 1, Part 1, after entry for Rivaroxaban in the form Tablet 10 mg [Brand: iXarola; Maximum Quantity: 60; Number of Repeats: 5] insert: Rivaroxaban Tablet 10 mg Oral Rivaroxaban Dr.Reddy's RZ MP NP C4402 P4402 30 0 30 Rivaroxaban Tablet 10 mg Oral Rivaroxaban Dr.Reddy's RZ MP NP C4132 P4132 30 5 30 Rivaroxaban Tablet 10 mg Oral Rivaroxaban Dr.Reddy's RZ MP NP C14300 P14300 60 5 30 [145] Schedule 1, Part 1, after entry for Rivaroxaban in the form Tablet 10 mg [Brand: Xarelto; Maximum Quantity: 60; Number of Repeats: 5] insert: Rivaroxaban Tablet 15 mg Oral ARX-Rivaroxaban 15 XT MP NP C4269 P4269 28 5 28 Rivaroxaban Tablet 15 mg Oral ARX-Rivaroxaban 15 XT MP NP C4098 C5098 P4098 P5098 42 0 42 Rivaroxaban Tablet 15 mg Oral ARX-Rivaroxaban 15 XT MP NP C14301 P14301 56 5 28 [146] Schedule 1, Part 1, after entry for Rivaroxaban in the form Tablet 15 mg [Brand: iXarola; Maximum Quantity: 56; Number of Repeats: 5] insert: Rivaroxaban Tablet 15 mg Oral Rivaroxaban Dr.Reddy's RZ MP NP C4269 P4269 28 5 28 Rivaroxaban Tablet 15 mg Oral Rivaroxaban Dr.Reddy's RZ MP NP C14301 P14301 56 5 28 [147] Schedule 1, Part 1, after entry for Rivaroxaban in the form Tablet 15 mg [Brand: Xarelto; Maximum Quantity: 56; Number of Repeats: 5] insert: Rivaroxaban Tablet 20 mg Oral ARX-Rivaroxaban 20 XT MP NP C4099 C4132 C4268 C4269 P4099 P4132 P4268 P4269 28 5 28 Rivaroxaban Tablet 20 mg Oral ARX-Rivaroxaban 20 XT MP NP C14264 C14300 C14301 C14318 P14264 P14300 P14301 P14318 56 5 28 [148] Schedule 1, Part 1, after entry for Rivaroxaban in the form Tablet 20 mg [Brand: iXarola; Maximum Quantity: 56; Number of Repeats: 5] insert: Rivaroxaban Tablet 20 mg Oral Rivaroxaban Dr.Reddy's RZ MP NP C4099 C4132 C4268 C4269 P4099 P4132 P4268 P4269 28 5 28 Rivaroxaban Tablet 20 mg Oral Rivaroxaban Dr.Reddy's RZ MP NP C14264 C14300 C14301 C14318 P14264 P14300 P14301 P14318 56 5 28 [149] Schedule 1, Part 1, entry for Saxagliptin with dapagliflozin in the form Tablet containing saxagliptin 5 mg with dapaglifozin 10 mg [Maximum Quantity: 28; Number of Repeats: 5] (a) omit from the column headed "Circumstances": C15269 substitute: C16290 (b) omit from the column headed "Purposes": P15269 substitute: P16290 [150] Schedule 1, Part 1, entry for Saxagliptin with dapagliflozin in the form Tablet containing saxagliptin 5 mg with dapaglifozin 10 mg [Maximum Quantity: 56; Number of Repeats: 5] (a) omit from the column headed "Circumstances": C15270 substitute: C16285 (b) omit from the column headed "Purposes": P15270 substitute: P16285 [151] Schedule 1, Part 1, after entry for Selinexor in the form Tablet 20 mg [Maximum Quantity: 32; Number of Repeats: 2] insert: Selpercatinib Capsule 40 mg Oral Retevmo LY MP C16270 56 5 56 Selpercatinib Capsule 80 mg Oral Retevmo LY MP C16282 112 5 56 [152] Schedule 1, Part 1, entries for Sunitinib substitute: Sunitinib Capsule 12.5 mg Oral Sunitinib Sandoz SZ MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 12.5 mg Oral Sunitinib Sandoz SZ MP C4862 P4862 28 2 28 Sunitinib Capsule 12.5 mg Oral Sunitinib Sandoz SZ MP C11875 P11875 28 3 28 Sunitinib Capsule 12.5 mg Oral Sunitinib Sandoz SZ MP C7471 P7471 28 5 28 Sunitinib Capsule 12.5 mg Oral Sutent PF MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 12.5 mg Oral Sutent PF MP C4862 P4862 28 2 28 Sunitinib Capsule 12.5 mg Oral Sutent PF MP C11875 P11875 28 3 28 Sunitinib Capsule 12.5 mg Oral Sutent PF MP C7471 P7471 28 5 28 Sunitinib Capsule 25 mg Oral ARX-Sunitinib XT MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 25 mg Oral ARX-Sunitinib XT MP C4862 P4862 28 2 28 Sunitinib Capsule 25 mg Oral ARX-Sunitinib XT MP C11875 P11875 28 3 28 Sunitinib Capsule 25 mg Oral ARX-Sunitinib XT MP C7471 P7471 28 5 28 Sunitinib Capsule 25 mg Oral Sunitinib Sandoz SZ MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 25 mg Oral Sunitinib Sandoz SZ MP C4862 P4862 28 2 28 Sunitinib Capsule 25 mg Oral Sunitinib Sandoz SZ MP C11875 P11875 28 3 28 Sunitinib Capsule 25 mg Oral Sunitinib Sandoz SZ MP C7471 P7471 28 5 28 Sunitinib Capsule 25 mg Oral Sutent PF MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 25 mg Oral Sutent PF MP C4862 P4862 28 2 28 Sunitinib Capsule 25 mg Oral Sutent PF MP C11875 P11875 28 3 28 Sunitinib Capsule 25 mg Oral Sutent PF MP C7471 P7471 28 5 28 Sunitinib Capsule 37.5 mg Oral ARX-Sunitinib XT MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 37.5 mg Oral ARX-Sunitinib XT MP C4862 P4862 28 2 28 Sunitinib Capsule 37.5 mg Oral ARX-Sunitinib XT MP C11875 P11875 28 3 28 Sunitinib Capsule 37.5 mg Oral ARX-Sunitinib XT MP C7471 P7471 28 5 28 Sunitinib Capsule 37.5 mg Oral Sunitinib Sandoz SZ MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 37.5 mg Oral Sunitinib Sandoz SZ MP C4862 P4862 28 2 28 Sunitinib Capsule 37.5 mg Oral Sunitinib Sandoz SZ MP C11875 P11875 28 3 28 Sunitinib Capsule 37.5 mg Oral Sunitinib Sandoz SZ MP C7471 P7471 28 5 28 Sunitinib Capsule 37.5 mg Oral Sutent PF MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 37.5 mg Oral Sutent PF MP C4862 P4862 28 2 28 Sunitinib Capsule 37.5 mg Oral Sutent PF MP C11875 P11875 28 3 28 Sunitinib Capsule 37.5 mg Oral Sutent PF MP C7471 P7471 28 5 28 Sunitinib Capsule 50 mg Oral ARX-Sunitinib XT MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 50 mg Oral ARX-Sunitinib XT MP C4862 P4862 28 2 28 Sunitinib Capsule 50 mg Oral ARX-Sunitinib XT MP C11875 P11875 28 3 28 Sunitinib Capsule 50 mg Oral ARX-Sunitinib XT MP C7471 P7471 28 5 28 Sunitinib Capsule 50 mg Oral Sunitinib Sandoz SZ MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 50 mg Oral Sunitinib Sandoz SZ MP C4862 P4862 28 2 28 Sunitinib Capsule 50 mg Oral Sunitinib Sandoz SZ MP C11875 P11875 28 3 28 Sunitinib Capsule 50 mg Oral Sunitinib Sandoz SZ MP C7471 P7471 28 5 28 Sunitinib Capsule 50 mg Oral Sutent PF MP C11878 C13152 C13153 P11878 P13152 P13153 28 1 28 Sunitinib Capsule 50 mg Oral Sutent PF MP C4862 P4862 28 2 28 Sunitinib Capsule 50 mg Oral Sutent PF MP C11875 P11875 28 3 28 Sunitinib Capsule 50 mg Oral Sutent PF MP C7471 P7471 28 5 28 [153] Schedule 1, Part 1, entries for Telmisartan in the form Tablet 40 mg omit: Telmisartan Tablet 40 mg Oral NOUMED TELMISARTAN VO MP NP 28 5 28 Telmisartan Tablet 40 mg Oral NOUMED TELMISARTAN VO MP NP P14238 56 5 28 [154] Schedule 1, Part 1, entries for Temazepam substitute: Temazepam Tablet 10 mg Oral APO-Temazepam TX PDP 25 0 25 Temazepam Tablet 10 mg Oral APO-Temazepam TX MP NP MW P16279 25 0 25 Temazepam Tablet 10 mg Oral APO-Temazepam TX MP NP P6175 50 CN6175 3 CN6175 25 Temazepam Tablet 10 mg Oral APO-Temazepam TX MP NP P5661 P5941 P5950 50 CN5661 CN5941 CN5950 5 CN5661 CN5941 CN5950 25 Temazepam Tablet 10 mg Oral Normison AS PDP 25 0 25 Temazepam Tablet 10 mg Oral Normison AS MP NP MW P16279 25 0 25 Temazepam Tablet 10 mg Oral Normison AS MP NP P6175 50 CN6175 3 CN6175 25 Temazepam Tablet 10 mg Oral Normison AS MP NP P5661 P5941 P5950 50 CN5661 CN5941 CN5950 5 CN5661 CN5941 CN5950 25 Temazepam Tablet 10 mg Oral Temaze AF PDP 25 0 25 Temazepam Tablet 10 mg Oral Temaze AF MP NP MW P16279 25 0 25 Temazepam Tablet 10 mg Oral Temaze AF MP NP P6175 50 CN6175 3 CN6175 25 Temazepam Tablet 10 mg Oral Temaze AF MP NP P5661 P5941 P5950 50 CN5661 CN5941 CN5950 5 CN5661 CN5941 CN5950 25 Temazepam Tablet 10 mg Oral TEMAZEPAM-WGR WG PDP 25 0 25 Temazepam Tablet 10 mg Oral TEMAZEPAM-WGR WG MP NP MW P16279 25 0 25 Temazepam Tablet 10 mg Oral TEMAZEPAM-WGR WG MP NP P6175 50 CN6175 3 CN6175 25 Temazepam Tablet 10 mg Oral TEMAZEPAM-WGR WG MP NP P5661 P5941 P5950 50 CN5661 CN5941 CN5950 5 CN5661 CN5941 CN5950 25 Temazepam Tablet 10 mg Oral Temtabs LN PDP 25 0 25 Temazepam Tablet 10 mg Oral Temtabs LN MP NP MW P16279 25 0 25 Temazepam Tablet 10 mg Oral Temtabs LN MP NP P6175 50 CN6175 3 CN6175 25 Temazepam Tablet 10 mg Oral Temtabs LN MP NP P5661 P5941 P5950 50 CN5661 CN5941 CN5950 5 CN5661 CN5941 CN5950 25 [155] Schedule 1, Part 1, entries for Tenofovir in the form Tablet containing tenofovir disoproxil maleate 300 mg omit: Tenofovir Tablet containing tenofovir disoproxil maleate 300 mg Oral Tenofovir Disoproxil Mylan AF MP NP C10362 P10362 60 2 30 D(100) Tenofovir Tablet containing tenofovir disoproxil maleate 300 mg Oral Tenofovir Disoproxil Mylan AF MP NP C6980 C6982 C6983 C6984 C6992 C6998 P6980 P6982 P6983 P6984 P6992 P6998 60 5 30 D(100) [156] Schedule 1, Part 1, after entry for Tiagabine in the form Tablet 15 mg (as hydrochloride) [Maximum Quantity: 200; Number of Repeats: 5] insert: Ticagrelor Tablet 90 mg Oral ARX-TICAGRELOR XT MP NP C5746 P5746 56 5 56 Ticagrelor Tablet 90 mg Oral ARX-TICAGRELOR XT MP NP C14240 P14240 112 5 56 [157] Schedule 1, Part 1, after entry for Ticagrelor in the form Tablet 90 mg [Brand: Brilinta; Maximum Quantity: 112; Number of Repeats: 5] insert: Ticagrelor Tablet 90 mg Oral TICALOR XE MP NP C5746 P5746 56 5 56 Ticagrelor Tablet 90 mg Oral TICALOR XE MP NP C14240 P14240 112 5 56 [158] Schedule 1, Part 1, entries for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg substitute: Tramadol Capsule containing tramadol hydrochloride 50 mg Oral APO-Tramadol TX MP NP MW C16276 P16276 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral APO-Tramadol TX PDP C10766 P10766 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral APO-Tramadol TX PDP C10768 P10768 20 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral APO-Tramadol TX MP NP C10764 C10771 C10772 P10764 P10771 P10772 20 0 V10764 V10771 V10772 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramadol Sandoz SZ MP NP MW C16276 P16276 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramadol Sandoz SZ PDP C10766 P10766 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramadol Sandoz SZ PDP C10768 P10768 20 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramadol Sandoz SZ MP NP C10764 C10771 C10772 P10764 P10771 P10772 20 0 V10764 V10771 V10772 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral TRAMADOL-WGR WG MP NP MW C16276 P16276 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral TRAMADOL-WGR WG PDP C10766 P10766 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral TRAMADOL-WGR WG PDP C10768 P10768 20 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral TRAMADOL-WGR WG MP NP C10764 C10771 C10772 P10764 P10771 P10772 20 0 V10764 V10771 V10772 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramal CS MP NP MW C16276 P16276 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramal CS PDP C10766 P10766 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramal CS PDP C10768 P10768 20 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramal CS MP NP C10764 C10771 C10772 P10764 P10771 P10772 20 0 V10764 V10771 V10772 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramedo AF MP NP MW C16276 P16276 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramedo AF PDP C10766 P10766 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramedo AF PDP C10768 P10768 20 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Tramedo AF MP NP C10764 C10771 C10772 P10764 P10771 P10772 20 0 V10764 V10771 V10772 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Zydol RW MP NP MW C16276 P16276 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Zydol RW PDP C10766 P10766 10 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Zydol RW PDP C10768 P10768 20 0 20 Tramadol Capsule containing tramadol hydrochloride 50 mg Oral Zydol RW MP NP C10764 C10771 C10772 P10764 P10771 P10772 20 0 V10764 V10771 V10772 20 [159] Schedule 1, Part 1, entry for Trimethoprim in the form Tablet 300 mg [Brand: Alprim; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [160] Schedule 1, Part 1, entry for Trimethoprim in the form Tablet 300 mg [Brand: Trimethoprim Viatris; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [161] Schedule 1, Part 1, entry for Trimethoprim in the form Tablet 300 mg [Brand: TRIMETHOPRIM-WGR; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [162] Schedule 1, Part 1, entry for Trimethoprim in the form Tablet 300 mg [Brand: Triprim; Maximum Quantity: 7; Number of Repeats: 1] omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW [163] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: APX-Valaciclovir; Maximum Quantity: 30; Number of Repeats: 5] substitute: Valaciclovir Tablet 500 mg (as hydrochloride) Oral APX-Valaciclovir TY MP NP MW C5940 P5940 30 5 30 Valaciclovir Tablet 500 mg (as hydrochloride) Oral APX-Valaciclovir TY MP NP C5961 P5961 30 5 30 [164] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: Shilova 500] substitute: Valaciclovir Tablet 500 mg (as hydrochloride) Oral Shilova 500 ZS MP NP MW C5940 30 5 30 Valaciclovir Tablet 500 mg (as hydrochloride) Oral Shilova 500 ZS MP NP C5961 30 5 30 [165] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: Vaclovir; Maximum Quantity: 30; Number of Repeats: 5] substitute: Valaciclovir Tablet 500 mg (as hydrochloride) Oral Vaclovir AF MP NP MW C5940 P5940 30 5 30 Valaciclovir Tablet 500 mg (as hydrochloride) Oral Vaclovir AF MP NP C5961 P5961 30 5 30 [166] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: Valaciclovir APOTEX; Maximum Quantity: 30; Number of Repeats: 5] substitute: Valaciclovir Tablet 500 mg (as hydrochloride) Oral Valaciclovir APOTEX GX MP NP MW C5940 P5940 30 5 30 Valaciclovir Tablet 500 mg (as hydrochloride) Oral Valaciclovir APOTEX GX MP NP C5961 P5961 30 5 30 [167] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: Valaciclovir RBX; Maximum Quantity: 30; Number of Repeats: 5] substitute: Valaciclovir Tablet 500 mg (as hydrochloride) Oral Valaciclovir RBX RA MP NP MW C5940 P5940 30 5 30 Valaciclovir Tablet 500 mg (as hydrochloride) Oral Valaciclovir RBX RA MP NP C5961 P5961 30 5 30 [168] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: Valaciclovir Sandoz; Maximum Quantity: 30; Number of Repeats: 5] substitute: Valaciclovir Tablet 500 mg (as hydrochloride) Oral Valaciclovir Sandoz SZ MP NP MW C5940 P5940 30 5 30 Valaciclovir Tablet 500 mg (as hydrochloride) Oral Valaciclovir Sandoz SZ MP NP C5961 P5961 30 5 30 [169] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: Valaciclovir SZ] substitute: Valaciclovir Tablet 500 mg (as hydrochloride) Oral Valaciclovir SZ HX MP NP MW C5940 30 5 30 Valaciclovir Tablet 500 mg (as hydrochloride) Oral Valaciclovir SZ HX MP NP C5961 30 5 30 [170] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: VALACICLOVIR-WGR; Maximum Quantity: 30; Number of Repeats: 5] substitute: Valaciclovir Tablet 500 mg (as hydrochloride) Oral VALACICLOVIR-WGR WG MP NP MW C5940 P5940 30 5 30 Valaciclovir Tablet 500 mg (as hydrochloride) Oral VALACICLOVIR-WGR WG MP NP C5961 P5961 30 5 30 [171] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: Valtrex; Maximum Quantity: 30; Number of Repeats: 5] substitute: Valaciclovir Tablet 500 mg (as hydrochloride) Oral Valtrex RW MP NP MW C5940 P5940 30 5 30 Valaciclovir Tablet 500 mg (as hydrochloride) Oral Valtrex RW MP NP C5961 P5961 30 5 30 [172] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: Zelitrex; Maximum Quantity: 30; Number of Repeats: 5] substitute: Valaciclovir Tablet 500 mg (as hydrochloride) Oral Zelitrex RF MP NP MW C5940 P5940 30 5 30 Valaciclovir Tablet 500 mg (as hydrochloride) Oral Zelitrex RF MP NP C5961 P5961 30 5 30 [173] Schedule 1, Part 1, entry for Vancomycin in the form Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) [Maximum Quantity: 5; Number of Repeats: 0] substitute: Vancomycin Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) Injection Vancomycin Viatris AL MP MW C5769 P5769 5 0 1 Vancomycin Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) Injection Vancomycin Viatris AL MP C5716 P5716 5 0 1 [174] Schedule 1, Part 1, entry for Vancomycin in the form Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) [Maximum Quantity: 3; Number of Repeats: 0] substitute: Vancomycin Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) Injection Vancomycin Viatris AL MP MW C5769 P5769 3 0 1 Vancomycin Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) Injection Vancomycin Viatris AL MP C5716 P5716 3 0 1 [175] Schedule 1, Part 2, omit entries for Alirocumab [176] Schedule 1, Part 2, omit entry for Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides [177] Schedule 1, Part 2, omit entries for Carmellose [178] Schedule 1, Part 2, omit entry for Carmellose with glycerin [179] Schedule 1, Part 2, omit entry for Glucose indicator-urine [180] Schedule 1, Part 2, omit entries for Niraparib [181] Schedule 3, omit table and substitute: Code Responsible Person ABN AB Abbott Australasia Pty Ltd 95 000 180 389 AE AFT Pharmaceuticals (AU) Pty Ltd 29 105 636 413 AF Alphapharm Pty Ltd 93 002 359 739 AL Alphapharm Pty Ltd 93 002 359 739 AN Amgen Australia Pty Limited 31 051 057 428 AP AstraZeneca Pty Ltd 54 009 682 311 AQ Alcon Laboratories (Australia) Pty Ltd 88 000 740 830 AS Aspen Pharmacare Australia Pty Limited 51 096 236 985 AV sanofi-aventis Australia Pty Ltd 31 008 558 807 BB Blackmores Limited 35 009 713 437 BD Biogen Australia Pty Ltd 30 095 760 115 BG Sandoz Pty Ltd 60 075 449 553 BN Bayer Australia Ltd 22 000 138 714 BQ Bristol-Myers Squibb Australia Pty Ltd 33 004 333 322 BX BAXTER HEALTHCARE PTY LTD 43 000 392 781 BY Boehringer Ingelheim Pty Ltd 52 000 452 308 BZ Boucher & Muir Pty Ltd 58 000 140 474 CF CNS Pharma Pty Ltd 76 121 515 400 CR Pharmacor Pty Limited 58 121 020 835 CS Seqirus (Australia) Pty Ltd 66 120 398 067 CX Contact Lens Centre Australia Limited 42 092 190 040 DE Stallergenes Australia Pty Ltd 17 151 366 540 DV Medical Developments International Limited 14 106 340 667 DX Ascensia Diabetes Care Australia Pty Limited 62 607 554 325 DZ Medsurge Healthcare Pty Ltd 92 124 728 892 EI Eisai Australia Pty Ltd 73 117 970 993 EJ Encapsulate Pharma Pty Ltd 80 640 718 289 EO Ego Pharmaceuticals Pty Ltd 86 005 142 361 EU Chiesi Australia Pty Ltd 72 145 180 865 EV Teva Pharma Australia Pty Ltd 41 169 715 664 EW Celltrion Healthcare Australia Pty Ltd 66 625 407 105 FB Pierre Fabre Australia Pty Ltd 30 098 999 850 FD Dr Falk Pharma Australia Pty Ltd 40 631 091 131 FF Phebra Pty Ltd 99 059 357 890 FG Phebra Pty Ltd 99 059 357 890 FI Boehringer Ingelheim Pty Ltd 52 000 452 308 FJ Pharmaco (Australia) Limited 89 113 383 501 FK A.Menarini Australia Pty Limited 62 116 935 758 FP Ferring Pharmaceuticals Pty Limited 87 003 037 170 FQ Pharmaco (Australia) Limited 89 113 383 501 FT AMICUS THERAPEUTICS PTY LTD 87 621 776 476 FX Gedeon Richter Australia Pty Ltd 98 602 550 274 FZ Pfizer Australia Pty Ltd 50 008 422 348 GA Galderma Australia Pty Ltd 12 003 976 930 GC GlaxoSmithKline Australia Pty Ltd 47 100 162 481 GH Amdipharm Mercury (Australia) Pty Limited 91 118 106 684 GI Gilead Sciences Pty Limited 71 072 611 708 GJ HALEON AUSTRALIA PTY LTD 68 603 310 292 GK GlaxoSmithKline Australia Pty Ltd 47 100 162 481 GO Viatris Pty Ltd 29 601 608 771 GQ Generic Health Pty Ltd 93 110 617 859 GT Viatris Pty Ltd 29 601 608 771 GX Apotex Pty Ltd 52 096 916 148 GZ sanofi-aventis Australia Pty Ltd 31 008 558 807 HB Besins Healthcare Australia Pty Ltd 68 164 882 062 HQ Generic Health Pty Ltd 93 110 617 859 HT BTC Speciality Health Pty Ltd 28 621 706 929 HW HAMELN PHARMA PTY. LTD. 69 638 348 580 HX Sandoz Pty Ltd 60 075 449 553 IB Apotex Pty Ltd 52 096 916 148 IE BeiGene AUS Pty Ltd 23 164 802 037 IL iNova Pharmaceuticals (Australia) Pty Limited 13 617 871 539 IM iNova Pharmaceuticals (Australia) Pty Limited 13 617 871 539 IO BioMarin Pharmaceutical Australia Pty Ltd 69 159 743 496 IQ Alcon Laboratories (Australia) Pty Ltd 88 000 740 830 IR Indivior Pty Ltd 22 169 280 102 IS Ipsen Pty Ltd 47 095 036 909 IT InterPharma Pty Ltd 19 099 877 899 IU AUPHARMA PTY LTD 84 132 146 313 IX Clinect Pty Ltd 76 150 558 473 IY Clinect Pty Ltd 76 150 558 473 JA JAZZ PHARMACEUTICALS ANZ PTY LTD 83 643 560 534 JC Janssen-Cilag Pty Ltd 47 000 129 975 JM Glenmark Pharmaceuticals (Australia) Pty Ltd 23 116 922 500 JO Juno Pharmaceuticals Pty Ltd 55 156 303 650 JT Johnson & Johnson Pacific Pty Limited 73 001 121 446 JU Juno Pharmaceuticals Pty Ltd 55 156 303 650 JX Juno Pharmaceuticals Pty Ltd 55 156 303 650 JZ Juniper Biologics Pty Ltd 97 655 479 897 KO KYOWA KIRIN AUSTRALIA PTY LTD 47 631 934 453 KP Eli Lilly Australia Pty Ltd 39 000 233 992 KQ PHERO PHARMA PTY LTD 96 673 730 231 KY Key Pharmaceuticals Pty Ltd 21 001 215 130 LG Leo Pharma Pty Ltd 72 147 880 617 LL Astellas Pharma Australia Pty Ltd 81 147 915 482 LM Link Medical Products Pty Ltd 73 010 971 516 LN Aspen Pharmacare Australia Pty Limited 51 096 236 985 LO Leo Pharma Pty Ltd 72 147 880 617 LQ Astellas Pharma Australia Pty Ltd 81 147 915 482 LR Cipla Australia Pty Ltd 46 132 155 063 LT Aspen Pharmacare Australia Pty Limited 51 096 236 985 LU Lundbeck Australia Pty Ltd 86 070 094 290 LX Lawley Pharmaceuticals Pty Ltd 12 095 973 523 LY Eli Lilly Australia Pty Ltd 39 000 233 992 MF Mundipharma Pty Limited 87 081 322 509 MK Merck Sharp & Dohme (Australia) Pty Ltd 14 000 173 508 MQ Alphapharm Pty Ltd 93 002 359 739 MW Biomed Aust Pty Limited 67 080 084 377 NB Nova Pharmaceuticals Australasia Pty Ltd 87 104 838 440 NE Norgine Pty. Ltd. 78 005 022 882 NF Novo Nordisk Pharmaceuticals Pty. Limited 40 002 879 996 NG NEON HEALTHCARE PTY LIMITED 57 670 586 526 NI Novo Nordisk Pharmaceuticals Pty. Limited 40 002 879 996 NM Novartis Pharmaceuticals Australia Pty Limited 18 004 244 160 NO Novo Nordisk Pharmaceuticals Pty. Limited 40 002 879 996 NP NICE-PAK PRODUCTS PTY. LTD. 71 051 956 346 NQ Takeda Pharmaceuticals Australia Pty. Ltd. 71 095 610 870 NT Nestle Australia Ltd 77 000 011 316 NU Nutricia Australia Pty Limited 99 076 246 752 NV Novartis Pharmaceuticals Australia Pty Limited 18 004 244 160 OC Accord Healthcare Pty. Ltd. 49 110 502 513 OD Accord Healthcare Pty. Ltd. 49 110 502 513 OE Omegapharm Pty Ltd 86 128 078 151 OH Orpharma Pty Ltd 19 157 901 267 OJ The Trustee for ORSPEC PHARMA UNIT TRUST 15 634 980 417 ON Orion Laboratories Pty. Ltd. 56 009 293 136 OQ Organon Pharma Pty Ltd 54 637 107 512 OS Otsuka Australia Pharmaceutical Pty. Ltd 20 601 768 754 OU Oraderm Pharmaceuticals Pty Ltd 50 612 828 618 OV Organon Pharma Pty Ltd 54 637 107 512 OW Arrow Pharma Pty Ltd 35 605 909 920 OX Orion Pharma (Aus) Pty Limited 15 654 099 608 PB Pharmaco (Australia) Limited 89 113 383 501 PF Pfizer Australia Pty Ltd 50 008 422 348 PK Fresenius Kabi Australia Pty Limited 39 109 383 593 PP Petrus Pharmaceuticals Pty Ltd 21 108 884 126 QH Cortex Health Pty Ltd 17 144 062 386 QS Sandoz Pty Ltd 60 075 449 553 QY Pro Pharmaceuticals Group Pty. Ltd. 20 605 457 430 RA Sun Pharma ANZ Pty Ltd 17 110 871 826 RB Bio Revive Pty Ltd 58 097 360 417 RF Arrow Pharma Pty Ltd 35 605 909 920 RI Dr Reddy's Laboratories (Australia) Pty Ltd 16 120 092 408 RJ Recordati Rare Diseases Australia Pty. Ltd. 26 627 263 094 RN Sun Pharma ANZ Pty Ltd 17 110 871 826 RO Roche Products Pty Ltd 70 000 132 865 RQ Reach Pharmaceuticals Pty Ltd 25 623 897 183 RW Arrow Pharma Pty Ltd 35 605 909 920 RX Servier Laboratories (Aust.) Pty. Ltd. 54 004 838 500 RZ Dr Reddy's Laboratories (Australia) Pty Ltd 16 120 092 408 SA SciGen (Australia) Pty Limited 76 055 016 969 SB Nutricia Australia Pty Limited 99 076 246 752 SE Servier Laboratories (Aust.) Pty. Ltd. 54 004 838 500 SG Merck Healthcare Pty Ltd 72 006 900 830 SI Sigma Company Limited 44 004 132 923 SN Smith & Nephew Pty Limited 68 000 087 507 SW sanofi-aventis Australia Pty Ltd 31 008 558 807 SY Bayer Australia Ltd 22 000 138 714 SZ Sandoz Pty Ltd 60 075 449 553 TB Teva Pharma Australia Pty Ltd 41 169 715 664 TD STADA Pharmaceuticals Australia Pty Limited 73 154 966 944 TG ANTENGENE (AUS) PTY. LTD. 30 638 038 990 TJ Taiho Pharma Oceania Pty Ltd 97 675 212 530 TK Takeda Pharmaceuticals Australia Pty. Ltd. 71 095 610 870 TN Medtas Pty Ltd 72 644 270 860 TQ Terumo BCT Australia Pty Limited 87 130 046 865 TS Specialised Therapeutics Australia Pty Ltd 73 124 031 241 TT Theramex Australia Pty Ltd 37 623 186 845 TW Apotex Pty Ltd 52 096 916 148 TX Apotex Pty Ltd 52 096 916 148 TY Apotex Pty Ltd 52 096 916 148 UC UCB Australia Proprietary Limited 48 005 799 208 UJ Upjohn Australia Pty Ltd 50 629 389 911 UL Bausch & Lomb (Australia) Pty Ltd 88 000 222 408 UO Bausch & Lomb (Australia) Pty Ltd 88 000 222 408 UR Camurus Pty Ltd 79 627 784 605 VB AbbVie Pty Ltd 48 156 384 262 VE AbbVie Pty Ltd 48 156 384 262 VF Vitaflo Australia Pty Limited 82 097 161 254 VI ViiV Healthcare Pty Ltd 46 138 687 448 VL Vifor Pharma Pty Limited 87 086 114 043 VO Avallon Pharmaceuticals Pty Limited 63 126 872 848 VQ Novartis Pharmaceuticals Australia Pty Limited 18 004 244 160 VR Vertex Pharmaceuticals (Australia) Pty. Ltd. 34 160 157 157 VZ Sanofi-aventis Healthcare Pty Ltd 43 076 651 959 WA sanofi-aventis Australia Pty Ltd 31 008 558 807 WG WAGNER PHARMACEUTICALS PTY LTD 48 670 339 867 WM MEDISON PHARMA AUSTRALIA PTY LIMITED 19 659 723 403 WZ Bridgewest Perth Pharma Pty Ltd 21 663 385 411 XC Southern Cross Pharma Pty Ltd 47 094 447 677 XE ACCELAGEN PTY LTD 11 142 888 766 XH MS Health Pty Ltd 33 155 182 586 XI Alexion Pharmaceuticals Australasia Pty Ltd 59 132 343 036 XN Southern XP Pty Ltd 34 639 505 481 XO Echo Therapeutics Pty Ltd 92 628 298 699 XT Arrotex Pharmaceuticals Pty Ltd 30 605 552 234 XW Arrotex Pharmaceuticals Pty Ltd 30 605 552 234 XY MAXX PHARMA PTY LTD 33 629 622 224 YG EUGIA PHARMA (AUSTRALIA) PTY LTD 57 656 083 028 YN Mayne Pharma International Pty Ltd 88 007 870 984 YO The Trustee for ORSPEC PHARMA UNIT TRUST 15 634 980 417 YT Mayne Products Pty Ltd 59 140 866 379 ZB Specialised Therapeutics Pm Pty Ltd 50 617 311 083 ZE Seekwell Pty Ltd 91 624 401 618 ZL Specialised Therapeutics Pharma Pty Ltd 77 609 261 430 ZO Swedish Orphan Biovitrum Pty Ltd 14 645 396 532 ZS Strides Pharma Science Pty Ltd 44 635 036 734 ZU Seekwell Pty Ltd 91 624 401 618 [182] Schedule 4, Part 1, omit entry for Circumstances Code "C5820" [183] Schedule 4, Part 1, omit entry for Circumstances Code "C5840" [184] Schedule 4, Part 1, omit entry for Circumstances Code "C5841" [185] Schedule 4, Part 1, omit entry for Circumstances Code "C5854" [186] Schedule 4, Part 1, omit entry for Circumstances Code "C6429" [187] Schedule 4, Part 1, omit entry for Circumstances Code "C13431" [188] Schedule 4, Part 1, omit entry for Circumstances Code "C13436" [189] Schedule 4, Part 1, omit entry for Circumstances Code "C13887" [190] Schedule 4, Part 1, entry for Circumstances Code "C15269" omit from the column headed "Listed Drug": Saxagliptin with dapagliflozin [191] Schedule 4, Part 1, entry for Circumstances Code "C15270" omit from the column headed "Listed Drug": Saxagliptin with dapagliflozin [192] Schedule 4, Part 1, omit entry for Circumstances Code "C16189" [193] Schedule 4, Part 1, entry for Circumstances Code "C16226" substitute: C16226 P16226 CN16226 Somatropin Severe growth hormone deficiency Compliance with Written Authority Required procedures Initial treatment of late onset growth hormone deficiency Must be treated by an endocrinologist. Patient must have onset of growth hormone deficiency secondary to organic hypothalamic or pituitary disease diagnosed at chronological age of 18 years or older; OR Patient must have onset of growth hormone deficiency diagnosed after skeletal maturity (bone age greater than or equal to 15.5 years in males or 13.5 years in females) and before chronological age of 18 years; AND Patient must have a diagnostic insulin tolerance test with maximum serum growth hormone (GH) less than 2.5 micrograms per litre; OR Patient must have a diagnostic arginine infusion test with maximum serum GH less than 0.4 micrograms per litre; OR Patient must have a diagnostic glucagon provocation test with maximum serum GH less than 3 micrograms per litre; OR Patient must have: (a) a chronological age of 18 years or older, (b) established hypothalamic-pituitary disease, (c) at least three documented pituitary hormone deficiencies, (d) an IGF-1 concentration lower than the sex- and age-specific lower limit of normal in a patient. The authority application must be in writing and must include: 1. Details of the proposed prescription; AND 2. A completed Severe Growth Hormone Deficiency supporting information form; AND 3. If applicable, results of the growth hormone simulation testing, including the date of testing, the type of test performed, the peak growth hormone concentration, and laboratory reference range for age/gender. [194] Schedule 4, Part 1, entry for Circumstances Code "C16242" substitute: C16242 P16242 CN16242 Somatropin Severe growth hormone deficiency Compliance with Written Authority Required procedures Initial treatment of childhood onset growth hormone deficiency in a patient who has received PBS-subsidised treatment as a child Must be treated by an endocrinologist. Patient must have a documented childhood onset growth hormone deficiency due to a congenital, genetic or structural cause; AND Patient must have previously received PBS-subsidised treatment with this drug for this condition as a child. Patient must have a mature skeleton. Somatropin is not PBS-subsidised for patients with Prader-Willi syndrome aged 18 years or older without a documented childhood onset Growth Hormone Deficiency. The authority application must be in writing and must include: 1. Details of the proposed prescription; AND 2. A completed Severe Growth Hormone Deficiency supporting information form. [195] Schedule 4, Part 1, entry for Circumstances Code "C16243" substitute: C16243 P16243 CN16243 Somatropin Severe growth hormone deficiency Compliance with Written Authority Required procedures Initial treatment of childhood onset growth hormone deficiency in a patient who has received non-PBS subsidised treatment as a child Must be treated by an endocrinologist. Patient must have a documented childhood onset growth hormone deficiency due to a congenital, genetic or structural cause; AND Patient must have previously received non-PBS subsidised treatment with this drug for this condition as a child; AND Patient must have current or historical evidence of an insulin tolerance test with maximum serum growth hormone (GH) less than 2.5 micrograms per litre; OR Patient must have current or historical evidence of an arginine infusion test with maximum serum GH less than 0.4 micrograms per litre; OR Patient must have current or historical evidence of a glucagon provocation test with maximum serum GH less than 3 micrograms per litre. Patient must have a mature skeleton. Somatropin is not PBS-subsidised for patients with Prader-Willi syndrome aged 18 years or older without a documented childhood onset Growth Hormone Deficiency. The authority application must be in writing and must include: 1. Details of the proposed prescription; AND 2. A completed Severe Growth Hormone Deficiency supporting information form; AND 3. Results of the growth hormone stimulation testing, including the date of testing, the type of test performed, the peak growth hormone concentration, and laboratory reference range for age/gender. [196] Schedule 4, Part 1, after entry for Circumstances Code "C16252" insert: C16261 P16261 CN16261 Enoxaparin For prescribing by certain health practitioners Labetalol Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) a nurse practitioner, (iii) an endorsed midwife who is each of: (a) sharing patient care with a medical practitioner for the current pregnancy episode, (b) continuing existing treatment with this drug that was initiated by a medical practitioner. Levothyroxine Metformin C16264 P16264 CN16264 Pembrolizumab Stage IV (metastatic) non-small cell lung cancer (NSCLC) Compliance with Authority Required procedures - Streamlined Authority Code 16264 Initial treatment - 6 weekly treatment regimen Patient must not have previously been treated for this condition in the metastatic setting; or The condition must have progressed after treatment with only one of (i) tepotinib, (ii) selpercatinib; AND Patient must not have received prior treatment with a programmed cell death-1 (PD-1) inhibitor or a programmed cell death ligand-1 (PD-L1) inhibitor for non-small cell lung cancer; AND Patient must have a WHO performance status of 0 or 1; AND The condition must not have evidence of an activating epidermal growth factor receptor (EGFR) gene or an anaplastic lymphoma kinase (ALK) gene rearrangement or a c-ROS proto-oncogene 1 (ROS1) gene arrangement in tumour material; AND The treatment must not exceed a total of 4 doses under this restriction. C16269 P16269 CN16269 Hydroxocobalamin Anaemias associated with vitamin B12 deficiency Patient must have had a gastrectomy; AND The treatment must be for prophylaxis; Patient must identify as Aboriginal or Torres Strait Islander; Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) a nurse practitioner, (iii) an endorsed midwife where patient care is being shared with a medical practitioner. C16270 P16270 CN16270 Selpercatinib Locally advanced or metastatic non-small cell lung cancer Compliance with Authority Required procedures - Streamlined Authority Code 16270 The condition must have evidence of rearranged during transfection (RET) gene fusion in tumour material - this evidence has been obtained prior to commencing treatment with this drug; AND Patient must have a World Health Organisation (WHO) Eastern Cooperative Oncology Group (ECOG) performance status score of no higher than 2 at treatment initiation; AND The treatment must be the sole PBS-subsidised systemic anti-cancer therapy for this PBS indication; AND Patient must be initiating treatment with this drug. or Patient must be continuing treatment with this drug, with an absence of further disease progression while being treated with this drug. Medical practitioners must prescribe the appropriate quantities of appropriate strength(s) to provide sufficient drug, based on the weight of the patient, adequate for 4 weeks per dispensing, according to the specified dosage in the approved Therapeutic Goods Administration (TGA) Product Information (PI). A separate authority prescription form must be completed for each strength requested. C16273 P16273 CN16273 Methyldopa Hypertension Compliance with Authority Required procedures Patient must be pregnant; Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) a nurse practitioner, an endorsed midwife who is each of: (a) sharing patient care with a medical practitioner for the current pregnancy episode, (b) continuing existing treatment with this drug that was initiated by a medical practitioner. C16274 P16274 CN16274 Methylphenidate Attention deficit hyperactivity disorder Compliance with Authority Required procedures Patient must have demonstrated a response to immediate-release methylphenidate hydrochloride with no emergence of serious adverse events; AND Patient must require continuous coverage over 12 hours; AND The treatment must not exceed a maximum daily dose of 72 mg of PBS-subsidised treatment with this drug; Patient must be or have been diagnosed between the ages of 6 and 18 years inclusive. C16276 P16276 CN16276 Oxycodone Severe pain Tramadol The treatment must be for short term therapy of acute severe pain; AND Patient must have had or would have inadequate pain management with maximum tolerated doses of non-opioid analgesics; or Patient must be unable to use non-opioid analgesics due to contraindications or intolerance; AND Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) a nurse practitioner, (iii) an endorsed midwife who is sharing the post-operative care of the patient with a medical practitioner. C16279 P16279 CN16279 Temazepam For prescribing by certain health practitioners Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) a nurse practitioner, (iii) an endorsed midwife where patient care is being shared with a medical practitioner. C16280 P16280 CN16280 Pembrolizumab Stage IV (metastatic) non-small cell lung cancer (NSCLC) Compliance with Authority Required procedures - Streamlined Authority Code 16280 Initial treatment - 3 weekly treatment regimen Patient must not have previously been treated for this condition in the metastatic setting; or The condition must have progressed after treatment with only one of (i) tepotinib, (ii) selpercatinib; AND Patient must not have received prior treatment with a programmed cell death-1 (PD-1) inhibitor or a programmed cell death ligand-1 (PD-L1) inhibitor for non-small cell lung cancer; AND Patient must have a WHO performance status of 0 or 1; AND The condition must not have evidence of an activating epidermal growth factor receptor (EGFR) gene or an anaplastic lymphoma kinase (ALK) gene rearrangement or a c-ROS proto-oncogene 1 (ROS1) gene arrangement in tumour material; AND The treatment must not exceed a total of 7 doses under this restriction. C16282 P16282 CN16282 Selpercatinib Locally advanced or metastatic non-small cell lung cancer Compliance with Authority Required procedures - Streamlined Authority Code 16282 The condition must have evidence of rearranged during transfection (RET) gene fusion in tumour material - this evidence has been obtained prior to commencing treatment with this drug; AND Patient must have a World Health Organisation (WHO) Eastern Cooperative Oncology Group (ECOG) performance status score of no higher than 2 at treatment initiation; AND The treatment must be the sole PBS-subsidised systemic anti-cancer therapy for this PBS indication; AND Patient must be initiating treatment with this drug. or Patient must be continuing treatment with this drug, with an absence of further disease progression while being treated with this drug. Medical practitioners must prescribe the appropriate quantities of appropriate strength(s) to provide sufficient drug, based on the weight of the patient, adequate for 4 weeks per dispensing, according to the specified dosage in the approved Therapeutic Goods Administration (TGA) Product Information (PI). A separate authority prescription form must be completed for each strength requested. Medical practitioners may prescribe selpercatinib 80 mg with a quantity of up to 56 units where the dose does not exceed 120 mg twice daily (i.e., in combination with selpercatinib 40 mg). Selpercatinib 80 mg with a quantity of 112 units must be prescribed only where the dose is 160 mg twice daily to provide 28 days of treatment per dispensing. Prescribers should refer to the TGA PI for dosing and dose adjustments regimens. C16285 P16285 CN16285 Saxagliptin with dapagliflozin Diabetes mellitus type 2 Compliance with Authority Required procedures The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND The treatment must be in combination with at least metformin; AND The condition must be inadequately responsive to dual therapy consisting of metformin with either: a DDP-4 inhibitor, an SGLT2 inhibitor; AND Patient must not be undergoing concomitant PBS-subsidised treatment with any of: a GLP-1 receptor agonist, another SGLT2 inhibitor, another DPP4 inhibitor. C16288 P16288 CN16288 Hydroxocobalamin Pernicious anaemia Patient must identify as Aboriginal or Torres Strait Islander; Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) a nurse practitioner, (iii) an endorsed midwife where patient care is being shared with a medical practitioner. C16289 P16289 CN16289 Hydroxocobalamin Proven vitamin B12 deficiencies other than pernicious anaemia Patient must identify as Aboriginal or Torres Strait Islander; Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) a nurse practitioner, (iii) an endorsed midwife where patient care is being shared with a medical practitioner. C16290 P16290 CN16290 Saxagliptin with dapagliflozin Diabetes mellitus type 2 Compliance with Authority Required procedures The treatment must be in combination with at least metformin; AND The condition must be inadequately responsive to dual therapy consisting of metformin with either: a DDP-4 inhibitor, an SGLT2 inhibitor; AND Patient must not be undergoing concomitant PBS-subsidised treatment with any of: a GLP-1 receptor agonist, another SGLT2 inhibitor, another DPP4 inhibitor. [197] Schedule 5, entry for Abiraterone [GRP-29273] insert as the first entry in the column headed "Brand": Abiraterone Sandoz [198] Schedule 5, entry for Abiraterone [GRP-29283] insert as the first entry in the column headed "Brand": Abiraterone Sandoz [199] Schedule 5, entry for Adalimumab in the form Injection 40 mg in 0.4 mL pre-filled syringe omit from the column headed "Brand": Adalicip [200] Schedule 5, omit entries for Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides [201] Schedule 5, entry for Amlodipine [GRP-19809] substitute: Amlodipine GRP-19809 Tablet 10 mg (as besilate) Oral Amlo 10 Amlodipine APOTEX Amlodipine GH Amlodipine Sandoz AMLODIPINE-WGR APO-Amlodipine APX-AMLODIPINE Blooms Amlodipine Blooms the Chemist Amlodipine Nordip Norvasc NOUMED AMLODIPINE Pharmacor Amlodipine [202] Schedule 5, after entry for Calcipotriol with betamethasone insert: Calcipotriol with betamethasone GRP-29366 Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g Application Enstilar Klarvanta [203] Schedule 5, after entry for Dabigatran etexilate [GRP-28127] insert: Dapsone GRP-29364 Tablet 100 mg Oral DAPSOMED Link Medical Products Pty Ltd [204] Schedule 5, entries for Estradiol substitute: Estradiol GRP-27217 Pessary (modified release) 10 micrograms (as hemihydrate) Vaginal Estro-Pess Vagifem Low Estradiol GRP-28649 Transdermal patches 585 micrograms, 8 Transdermal Estradiol Transdermal System (Sandoz, USA) Estradot 37.5 Estradiol GRP-28651 Transdermal patches 1.17 mg, 8 Transdermal Estradiol Transdermal System (Sandoz, USA) Estradot 75 Estradiol GRP-28652 Transdermal patches 1.56 mg, 8 Transdermal Estradiol Transdermal System (Sandoz, USA) Estradot 100 Estradiol GRP-29372 Transdermal patches 780 micrograms, 24 (S19A) Transdermal Estramon (Germany, Sandoz) Estramon 50 (Germany) Estradiol GRP-29376 Transdermal patches 1.17 mg, 24 (S19A) Transdermal Estramon (Germany, Sandoz) Estramon 75 (Germany) [205] Schedule 5, entries for Fenofibrate substitute: Fenofibrate GRP-20716 Tablet 145 mg Oral APO-Fenofibrate BTC Fenofibrate Fenocol Fenofibrate Cipla Fenofibrate Lupin FENOFIBRATE RBX Fenofibrate Sandoz Fenofibrate Viatris FENOFIBRATE-WGR Lipidil Fenofibrate GRP-20725 Tablet 48 mg Oral APO-Fenofibrate Fenofibrate Cipla Fenofibrate Lupin FENOFIBRATE RBX Fenofibrate Viatris FENOFIBRATE-WGR Lipidil [206] Schedule 5, entry for Ganirelix insert as the first entry in the column headed "Brand": ARX Ganirelix [207] Schedule 5, after entry for Macrogol 3350 insert: Maraviroc GRP-29369 Tablet 300 mg Oral Celsentri Maraviroc Waymade Maraviroc GRP-29377 Tablet 150 mg Oral Celsentri Maraviroc Waymade [208] Schedule 5, entry for Mirtazapine [GRP-19763] omit from the column headed "Brand": NOUMED MIRTAZAPINE [209] Schedule 5, omit entries for Niraparib [210] Schedule 5, entry for Pirfenidone [GRP-27890] insert as the first entry in the column headed "Brand": ARX-Pirfenidone [211] Schedule 5, entry for Pirfenidone [GRP-27892] omit from the column headed "Form": Tablet 801mg substitute: Tablet 801 mg [212] Schedule 5, entries for Rivaroxaban substitute: Rivaroxaban GRP-29154 Tablet 2.5 mg Oral Rivaroxaban-Teva RIVOXA Xarelto Rivaroxaban GRP-29164 Tablet 20 mg Oral ARX-Rivaroxaban 20 iXarola Rivaroxaban Dr.Reddy's Rivaroxaban Sandoz Rivaroxaban-Teva Rivoxa Xarelto Rivaroxaban GRP-29169 Tablet 10 mg Oral ARX-Rivaroxaban 10 iXarola Rivaroxaban Dr.Reddy's Rivaroxaban Sandoz Rivaroxaban-Teva Rivoxa Xarelto Rivaroxaban GRP-29173 Tablet 15 mg Oral ARX-Rivaroxaban 15 iXarola Rivaroxaban Dr.Reddy's Rivaroxaban Sandoz Rivaroxaban-Teva Rivoxa Xarelto [213] Schedule 5, entry for Telmisartan [GRP-19604] omit from the column headed "Brand": NOUMED TELMISARTAN [214] Schedule 5, entry for Tenofovir in the form Tablet containing tenofovir disoproxil maleate 300 mg omit from the column headed "Brand": Tenofovir Disoproxil Mylan [215] Schedule 5, after entry for Tetrabenazine insert: Ticagrelor GRP-29370 Tablet 90 mg Oral ARX-TICAGRELOR Brilinta TICALOR